<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://archotol.ama-assn.org">
<title>Archives of Otolaryngology recent issues</title>
<link>http://archotol.ama-assn.org</link>
<description>Archives of Otolaryngology - Head &amp; Neck Surgery provides timely information for physicians and scientists concerned with diseases of the head and neck.  Published monthly, it includes peer-reviewed clinical and basic research from an array of disciplines. Archives is the official publication for the American Academy of Facial Plastic and Reconstructive Surgery, Inc., the American Head and Neck Society, and the American Society of Pediatric Otolaryngology.</description>
<prism:publicationName>Archives of Otolaryngology - Head and Neck Surgery</prism:publicationName>
<prism:issn>0886-4470</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/962?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/963?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/966?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/970?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/976?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/984?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/988?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/994?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/1000?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/1005?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/1010?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/1015?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/1019?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/1024?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/1030?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/1035?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/1041?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/1045?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/1048?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/1052?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/1053?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/1054?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/1055?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/1056?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/1057?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/1058?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/10/1059?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/845?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/846?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/851?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/860?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/869?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/876?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/882?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/887?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/896?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/903?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/910?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/915?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/920?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/924?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/932?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/936?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/940?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/941?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/942?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/943?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/944?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/945?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/946?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/947?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/949?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/952?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/9/953?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/733?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/734?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/738?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/742?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/748?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/752?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/759?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/764?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/771?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/776?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/781?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/784?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/789?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/795?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/801?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/807?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/812?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/818?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/821?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/824?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/828?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/829?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/830?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/831?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/832?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/833?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/834?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/835?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/836?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/8/836-a?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/629?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/630?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/634?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/636?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/638?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/642?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/647?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/652?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/657?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/662?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/670?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/677?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/682?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/686?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/687?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/694?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/704?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/712?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/714?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/716?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/717?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/718?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/719?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/720?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/721?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/722?rss=1" />
  <rdf:li rdf:resource="http://archotol.ama-assn.org/cgi/content/short/135/7/723?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://archotol.ama-assn.org/icons/misc/titlereprint.gif" />
</channel>

<image rdf:about="http://archotol.ama-assn.org/icons/misc/titlereprint.gif">
<title>Archives of Otolaryngology - Head and Neck Surgery</title>
<url>http://archotol.ama-assn.org/icons/misc/titlereprint.gif</url>
<link>http://archotol.ama-assn.org</link>
</image>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/962?rss=1">
<title><![CDATA[Common paintbrush [About the Cover]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/962?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:04 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Otolaryngology/ Head & Neck Surgery, Other, Humanities]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.156</dc:identifier>
<dc:title><![CDATA[Common paintbrush [About the Cover]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>962</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>962</prism:startingPage>
<prism:section>About the Cover</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/963?rss=1">
<title><![CDATA[About This Journal [About This Journal]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/963?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:04 PDT</dc:date>
<dc:title><![CDATA[About This Journal [About This Journal]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>963</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>963</prism:startingPage>
<prism:section>About This Journal</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/966?rss=1">
<title><![CDATA[Impact of Tonsillectomy With or Without Adenoidectomy on the Acoustic Parameters of the Voice: A Comparative Study [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/966?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To assess the effects of chronic tonsillitis with or without adenoiditis and the effects of tonsillectomy with or without adenoidectomy on the voice by means of acoustic analysis.</p>
<p><b>Design&nbsp;</b> Prospective case-control study.</p>
<p><b>Setting&nbsp;</b> Yenepoya Medical College Hospital, a tertiary referral hospital.</p>
<p><b>Patients&nbsp;</b> Patients 5 to 26 years old with chronic tonsillitis with or without adenoiditis.</p>
<p><b>Interventions&nbsp;</b> Tonsillectomies were performed under general anesthesia by surgeons using cold steel instruments via a standard capsular dissection technique, and adenoids were removed by curettage.</p>
<p><b>Main Outcome Measures&nbsp;</b> Acoustic analysis of 6 parameters (fundamental frequency, jitter, shimmer, harmonics: noise ratio, long-term average spectrum, and nasalance) 4 weeks after surgery compared with 1 day before surgery.</p>
<p><b>Results&nbsp;</b> Postoperatively, shimmer altered in males, and hypernasality was eliminated in almost all cases. None of the other associations were significant statistically.</p>
<p><b>Conclusions&nbsp;</b> Chronic tonsillitis and tonsillar hypertrophy cause alterations in some acoustic measurements, which make the voice dysharmonic and harsh. Tonsillectomy eliminates nasalance and lowers shimmer. Overall, it does not significantly alter dysphonia owing to disease.</p>
]]></description>
<dc:creator><![CDATA[Subramaniam, V., Kumar, P.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:04 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Pediatric Otolaryngology, Voice Disorders, Otolaryngology/ Head & Neck Surgery, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.136</dc:identifier>
<dc:title><![CDATA[Impact of Tonsillectomy With or Without Adenoidectomy on the Acoustic Parameters of the Voice: A Comparative Study [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>969</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>966</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/970?rss=1">
<title><![CDATA[Influence of Single-Trial Results on Clinical Practice: Example of Adenotonsillectomy in Children [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/970?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To establish whether the results of a 2004 trial on the effectiveness of adenotonsillectomy in children with mild to moderate symptoms of throat infection or adenotonsillar hypertrophy affected physicians' beliefs about the benefits of the operation and influenced clinical practice.</p>
<p><b>Design&nbsp;</b> Prospective prior-posterior study.</p>
<p><b>Setting&nbsp;</b> Academic research.</p>
<p><b>Participants&nbsp;</b> We evaluated beliefs prior and posterior to the 2004 trial regarding the benefits of adenotonsillectomy in a random sample of 120 Dutch otolaryngologists and 120 Dutch general practitioners.</p>
<p><b>Main Outcome Measure&nbsp;</b> Physicians were asked to give their estimates of the probability of recovery during 1 year after adenotonsillectomy or a nonsurgical strategy in 3 scenarios of children aged 3 to 4 years with recurrent throat infection, upper respiratory tract infection (with or without fever), or sleep-related breathing disorder.</p>
<p><b>Results&nbsp;</b> Ninety-four percent of otolaryngologists (n&nbsp;=&nbsp;46) and 31% of general practitioners (n&nbsp;=&nbsp;14) were familiar with the 2004 trial results. Posterior beliefs of otolaryngologists and general practitioners did not differ substantially from prior beliefs; overall expectations regarding the benefits of adenotonsillectomy remained high.</p>
<p><b>Conclusion&nbsp;</b> Dissemination of the 2004 trial results did not seem to affect the beliefs of physicians regarding the benefits of adenotonsillectomy.</p>
<p><b>Trial Registration&nbsp;</b> isrctn.org Identifier: <inter-ref locator-type="url" locator="http://controlled-trials.com/ISRCTN04973569">ISRCTN04973569</inter-ref></p>
]]></description>
<dc:creator><![CDATA[Rovers, M. M., Hoes, A. W., Klinkhamer, S., Schilder, A. G. M.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:04 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Pediatric Otolaryngology, Otolaryngology/ Head & Neck Surgery, Other, Pediatrics, Pediatrics, Other, Quality of Care, Evidence-Based Medicine, Statistics and Research Methods]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.150</dc:identifier>
<dc:title><![CDATA[Influence of Single-Trial Results on Clinical Practice: Example of Adenotonsillectomy in Children [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>975</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>970</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/976?rss=1">
<title><![CDATA[Microcystic Lymphatic Malformations of the Tongue: Diagnosis, Classification, and Treatment [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/976?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To describe a classification of microcystic lymphatic malformations of the tongue and to investigate different treatment methods.</p>
<p><b>Design&nbsp;</b> Retrospective review of patients treated for microcystic lymphatic malformations of the tongue. Lymphatic malformations were classified into the following 4 groups according to their extent: isolated superficial microcystic lymphatic malformations of the tongue (stage I); isolated lymphatic malformations of the tongue with muscle involvement (stage II; stage IIA, involving a part of the tongue; stage IIB, involving the entire tongue); microcystic lymphatic malformations of the tongue and the floor of mouth (stage III); and extensive microcystic lymphatic malformations involving the tongue, floor of mouth, and further cervical structures (stage IV).</p>
<p><b>Patients&nbsp;</b> Twenty patients with microcystic lymphatic malformation of the tongue.</p>
<p><b>Main Outcome Measures&nbsp;</b> Medical records were reviewed for demographic data and extent and treatment of the lymphatic malformations.</p>
<p><b>Results&nbsp;</b> Three patients had stage I disease; 5 patients, stage II; 3 patients, stage III; and 9 patients, stage IV. In 6 patients, the lymphatic malformations could be completely removed by carbon dioxide laser surgery; the remaining 13 patients had persistent disease.</p>
<p><b>Conclusions&nbsp;</b> The initial stage seems to predict outcome. Carbon dioxide laser therapy provides good results primarily in stages I and IIA lymphatic malformations. In advanced lymphatic malformations (stages IIB, III, and IV), an interdisciplinary approach is necessary, because complete surgical excision is often impossible owing to the diffuse growth behavior, and therefore recurrence and persistence are common.</p>
]]></description>
<dc:creator><![CDATA[Wiegand, S., Eivazi, B., Zimmermann, A. P., Neff, A., Barth, P. J., Sesterhenn, A. M., Mandic, R., Werner, J. A.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:04 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Congenital Anomalies of Head & Neck, Otolaryngology/ Head & Neck Surgery, Other, Surgery, Surgical Interventions, Laser Surgery, Surgical Interventions, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.131</dc:identifier>
<dc:title><![CDATA[Microcystic Lymphatic Malformations of the Tongue: Diagnosis, Classification, and Treatment [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>983</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>976</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/984?rss=1">
<title><![CDATA[Duration-Related Efficacy of Postoperative Antibiotics Following Pediatric Tonsillectomy: A Prospective, Randomized, Placebo-Controlled Trial [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/984?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To determine whether a 3-day course of postoperative antibiotics is as effective as a 7-day course in reducing pain and reducing time to resumption of a normal diet and level of activity following pediatric tonsillectomy.</p>
<p><b>Design&nbsp;</b> A prospective, randomized, placebo-controlled trial.</p>
<p><b>Setting&nbsp;</b> Academic medical center.</p>
<p><b>Patients&nbsp;</b> Forty-nine patients were enrolled in the study. Preoperative demographic information was obtained.</p>
<p><b>Interventions&nbsp;</b> Tonsillectomy with or without adenoidectomy was performed by the senior author (J.J.) using electrocautery. Patients were randomized to receive either a 3- or 7-day course of amoxicillin.</p>
<p><b>Main Outcome Measures&nbsp;</b> Parents were asked to record the following information: analgesic use for the first 7 postoperative days, postoperative days the child initiated his or her usual diet and level of activity, and medical treatment for oral hemorrhage or dehydration.</p>
<p><b>Results&nbsp;</b> Of the 49 patients, 26 were randomized to receive 7 days of postoperative antibiotics (group A) and 23 to receive 3 days of antibiotics, followed by 4 days of placebo (group B). Results were obtained for 47 of the enrolled patients (96%). No statistically significant difference was noted between the 2 groups with regard to postoperative pain or time to resumption of a normal diet and level of activity.</p>
<p><b>Conclusion&nbsp;</b> A 3-day course of antibiotics following pediatric tonsillectomy is as effective as a 7-day course with regard to postoperative analgesic use and resumption of normal diet and level of activity.</p>
<p><b>Trial Registration&nbsp;</b> clinicaltrials.gov Identifier: <inter-ref locator-type="url" locator="http://clinicaltrials.gov/show/NCT00662987">NCT00662987</inter-ref></p>
]]></description>
<dc:creator><![CDATA[Johnson, P. E., Rickert, S. M., Jones, J.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:04 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Pediatric Otolaryngology, Otolaryngology/ Head & Neck Surgery, Other, Pediatrics, Pediatrics, Other, Randomized Controlled Trial, Prognosis/ Outcomes, Drug Therapy, Drug Therapy, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.146</dc:identifier>
<dc:title><![CDATA[Duration-Related Efficacy of Postoperative Antibiotics Following Pediatric Tonsillectomy: A Prospective, Randomized, Placebo-Controlled Trial [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>987</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>984</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/988?rss=1">
<title><![CDATA[Clinical Implication of the Olfactory Cleft in Patients With Chronic Rhinosinusitis and Olfactory Loss [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/988?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To evaluate the relationship between findings via osteomeatal unit computed tomography (OMU CT) of the olfactory cleft and olfactory function in patients with chronic rhinosinusitis (CRS).</p>
<p><b>Design&nbsp;</b> Retrospective review of medical records.</p>
<p><b>Setting&nbsp;</b> Referral center.</p>
<p><b>Participants&nbsp;</b> Two hundred ten patients with CRS who underwent OMU CT and olfactory function tests were included in this study.</p>
<p><b>Main Outcome Measures&nbsp;</b> All the paranasal sinuses were graded via the Lund-Mackay scoring system. The olfactory cleft was graded on a scale of 0 to 4 according to its opacification. Olfactory function was evaluated by the butanol threshold test (BTT) and the 16-odor identification test (OIT).</p>
<p><b>Results&nbsp;</b> The radiologic grade of the olfactory cleft was more significantly correlated with olfactory function than the grades of the paranasal sinuses. In patients without allergy, the BTT and OIT scores were inversely correlated with the CT score of the olfactory cleft. However, in patients with allergy, only the BTT score had a negative correlation with the CT score of the olfactory cleft, whereas the OIT score did not. The OIT score showed a significant negative correlation with the opacification of the olfactory cleft in the mild and moderate CRS group only, whereas the BTT score showed a significant negative correlation in all stages of CRS.</p>
<p><b>Conclusions&nbsp;</b> The opacification of the olfactory cleft had a negative correlation with the olfactory function scores in patients with CRS. The olfactory cleft findings on OMU CT may give some clues to the olfactory function in patients with CRS.</p>
]]></description>
<dc:creator><![CDATA[Chang, H., Lee, H. J., Mo, J.-H., Lee, C. H., Kim, J.-W.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:04 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, General Rhinology, Olfaction and Taste Disorders, Paranasal Sinus Disease, Radiologic Imaging, Computed Tomography]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.140</dc:identifier>
<dc:title><![CDATA[Clinical Implication of the Olfactory Cleft in Patients With Chronic Rhinosinusitis and Olfactory Loss [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>992</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>988</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/994?rss=1">
<title><![CDATA[Relative Hypotension and Image Guidance: Tools for Training in Sinus Surgery [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/994?rss=1</link>
<description><![CDATA[
<p><b>Objectives&nbsp;</b> To quantify the safety and efficiency of Postgraduate-Year II head-and-neck-surgery residents who perform endoscopic sinus surgery, to observe any changes that accompanied accrued experience, and to measure and correlate blood loss and temporal efficiency with anesthesia-induced relative hypotension.</p>
<p><b>Design&nbsp;</b> Retrospective study.</p>
<p><b>Setting&nbsp;</b> University of California, San Diego, Medical Center.</p>
<p><b>Patients&nbsp;</b> One hundred two patients with chronic rhinosinusitis operated on between July 1, 2005, and June 30, 2006, by 3 Postgraduate-Year II head-and-neck-surgery residents.</p>
<p><b>Intervention&nbsp;</b> Endoscopic sinus surgery.</p>
<p><b>Main Outcome Measures&nbsp;</b> Operative times, blood loss, case complexity, and anesthetic components were recorded and analyzed.</p>
<p><b>Results&nbsp;</b> One hundred two patients with chronic rhinosinusitis with and without polyposis received operative management. Mean operative time, with the inclusion of injection (10 minutes) and image guidance setup (5 minutes), was 77 minutes. Estimated blood loss averaged 42 mL for patients with chronic rhinosinusitis and 58 mL for patients with chronic rhinosinusitis and nasal polyps. The mean intraoperative blood pressure was 101/65 mm Hg. No major complications occurred.</p>
<p><b>Conclusions&nbsp;</b> Endoscopic sinus surgery may be safely performed by Postgraduate-Year II head-and-neck-surgery residents by means of hypotensive anesthesia techniques and image guidance. Outcome analysis demonstrates minimal blood loss, efficient operative times, and no significant complications.</p>
]]></description>
<dc:creator><![CDATA[Crawley, B. K., Barkdull, G. C., Dent, S., Bishop, M., Davidson, T. M.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:04 PDT</dc:date>
<dc:subject><![CDATA[Medical Practice, Medical Education, Cardiovascular System, Other, Anesthesia, Otolaryngology/ Head & Neck Surgery, General Rhinology, Paranasal Sinus Disease, Cardiovascular System, Quality of Care, Patient Safety/ Medical Error, Surgery, Surgical Interventions, Endoscopy/ Minimally Invasive Surgery]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.139</dc:identifier>
<dc:title><![CDATA[Relative Hypotension and Image Guidance: Tools for Training in Sinus Surgery [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>999</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>994</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/1000?rss=1">
<title><![CDATA[Treatment of Postviral Olfactory Loss With Glucocorticoids, Ginkgo biloba, and Mometasone Nasal Spray [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/1000?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To analyze the efficacy of treating postviral olfactory loss with glucocorticoids, <I>Ginkgo biloba</I>, and mometasone furoate nasal spray.</p>
<p><b>Design&nbsp;</b> Randomized trial.</p>
<p><b>Setting&nbsp;</b> Academic research.</p>
<p><b>Patients&nbsp;</b> Seventy-one patients who were diagnosed as having postviral olfactory loss.</p>
<p><b>Main Outcome Measures&nbsp;</b> All patients underwent olfactory function tests, including the butanol threshold test (BTT) and the cross-cultural smell identification test (CCSIT), and follow-up tests were performed 4 weeks later. In the interim, 28 patients were treated with prednisolone for 2 weeks (monotherapy), and the other 43 patients were treated with prednisolone for 2 weeks plus <I>G biloba</I> for 4 weeks (combination therapy). All patients used mometasone nasal spray twice daily for 4 weeks.</p>
<p><b>Results&nbsp;</b> Scores on the BTT and CCSIT significantly increased after treatment in both groups (<I>P</I>&nbsp;&lt;&nbsp;.001 for both). The mean (SD) BTT score changes were 1.4 (2.2) in the monotherapy group and 2.2 (2.9) in the combination therapy group (<I>P</I>&nbsp;=&nbsp;.22). The mean (SD) CCSIT score changes were 0.9 (1.7) in the monotherapy group and 1.9 (2.7) in the combination therapy group (<I>P</I>&nbsp;=&nbsp;.11). On the BTT, the treatment response (defined as a score increase of &ge;3) rates were 32% (9 of 28) in the monotherapy group and 37% (16 of 43) in the combination therapy group (<I>P</I>&nbsp;=&nbsp;.66), and the odds ratio was 1.25 (95% confidence interval, 0.46-3.42). On the CCSIT, the treatment response rates were 14% (4 of 28) in the monotherapy group and 33% (14 of 43) in the combination therapy group (<I>P</I>&nbsp;=&nbsp;.08), and the odds ratio was 2.89 (95% confidence interval, 0.84-9.97).</p>
<p><b>Conclusions&nbsp;</b> Olfactory function in patients with postviral olfactory loss was significantly improved by both treatment modalities. Although the treatment response was not statistically different between the monotherapy group and the combination therapy group, the addition of <I>G biloba</I> showed a tendency of greater efficacy in the treatment of postviral olfactory loss.</p>
]]></description>
<dc:creator><![CDATA[Seo, B. S., Lee, H. J., Mo, J.-H., Lee, C. H., Rhee, C.-S., Kim, J.-W.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:04 PDT</dc:date>
<dc:subject><![CDATA[Viral Infections, Complementary and Alternative Medicine, Otolaryngology/ Head & Neck Surgery, Olfaction and Taste Disorders, Randomized Controlled Trial, Drug Therapy, Drug Therapy, Other, Infectious Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.141</dc:identifier>
<dc:title><![CDATA[Treatment of Postviral Olfactory Loss With Glucocorticoids, Ginkgo biloba, and Mometasone Nasal Spray [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>1004</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1000</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/1005?rss=1">
<title><![CDATA[The Hemostatic and Hemodynamic Effects of Epinephrine During Endoscopic Sinus Surgery: A Randomized Clinical Trial [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/1005?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To assess the hemodynamic and hemostatic effects of 2 different concentrations of epinephrine in local anesthetic used during functional endoscopic sinus surgery (FESS). Injection of local anesthetic containing epinephrine during endoscopic sinus surgery, while providing hemostasis, has been associated with cardiac adverse effects such as tachycardia, hypertension, as well as arrhythmias.</p>
<p><b>Design&nbsp;</b> Double-blind, randomized clinical trial.</p>
<p><b>Setting&nbsp;</b> Tertiary referral center.</p>
<p><b>Patients&nbsp;</b> A total of 140 patients undergoing FESS randomly divided into 2 groups, with group 1 receiving lidocaine hydrochloride, 2%, with 1:100&nbsp;000 epinephrine and group 2, lidocaine, 2%, with 1:200&nbsp;000 epinephrine.</p>
<p><b>Main Outcome Measures&nbsp;</b> Baseline and postinjection hemodynamic parameters were recorded at 1-minute intervals for 5 minutes. Patient demographics, the extent of surgery, and the presence of polyps were recorded in both groups. Hemodynamic and hemostatic parameters and intraoperative blood loss were compared.</p>
<p><b>Results&nbsp;</b> Significant hemodynamic fluctuations were noted following injection of lidocaine, 2%, with 1:100&nbsp;000 epinephrine (group 1). Increases in heart rate and systolic, diastolic, and mean arterial blood pressure were noted in group 1 patients. The increase was found to be significant (<I>P&nbsp;</I>&lt;&nbsp;.001) in the first and second minutes after injection and decreased to baseline level by the fifth minute. This fluctuation was not noted in group 2 patients, who received lidocaine, 2%, with 1:200&nbsp;000 epinephrine. Using a standardized scale to assess surgical bleeding, no statistical difference in the 2 groups was observed (<I>P&nbsp;</I>>&nbsp;.05).</p>
<p><b>Conclusion&nbsp;</b> Submucosal injection of lidocaine, 2%, with 1:200&nbsp;000 epinephrine during FESS does not lead to hemodynamic fluctuations or increased intraoperative bleeding compared with lidocaine, 2%, with 1:100&nbsp;000 epinephrine.</p>
<p><b>Trial Registration&nbsp;</b> clinicaltrials.gov Identifier: <inter-ref locator-type="url" locator="http://clinicaltrials.gov/show/NCT00852410">NCT00852410</inter-ref></p>
]]></description>
<dc:creator><![CDATA[Moshaver, A., Lin, D., Pinto, R., Witterick, I. J.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:04 PDT</dc:date>
<dc:subject><![CDATA[Anesthesia, Otolaryngology/ Head & Neck Surgery, Anesthesia of Head & Neck, Endoscopy of Upper Aerodigestive Tract, Paranasal Sinus Disease, Surgery, Surgical Interventions, Surgical Interventions, Other, Randomized Controlled Trial]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.144</dc:identifier>
<dc:title><![CDATA[The Hemostatic and Hemodynamic Effects of Epinephrine During Endoscopic Sinus Surgery: A Randomized Clinical Trial [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>1009</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1005</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/1010?rss=1">
<title><![CDATA[A New Surgical Method of Dynamic Nasal Valve Collapse [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/1010?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To describe a technique for internal nasal valve collapse using radiofrequency-induced thermotherapy (RFITT).</p>
<p><b>Design&nbsp;</b> Prospective study.</p>
<p><b>Setting&nbsp;</b> Academic research center.</p>
<p><b>Patients&nbsp;</b> A total of 28 patients with nasal obstruction due to inspiratory nasal valve collapse were included in this study.</p>
<p><b>Intervention&nbsp;</b> Radiofrequency-induced thermotherapy.</p>
<p><b>Main Outcome Measures&nbsp;</b> Visual analog scale score.</p>
<p><b>Results&nbsp;</b> Severity of obstruction scores improved in all patients, with the mean score improving at the left nostril from 8.2 before treatment to 3.4 after treatment and at the right nostril from 8.9 before treatment to 4.1 after treatment. The outcomes were measured using visual analog scale score before treatment and at 16 weeks after treatment. Improvement was shown in severity of obstruction (<I>P</I>&nbsp;&lt;&nbsp;.001).</p>
<p><b>Conclusions&nbsp;</b> This new method appears to be safe, quick, bloodless, and painless. These good, encouraging preliminary results must be confirmed by further study and long-term follow-up.</p>
]]></description>
<dc:creator><![CDATA[Seren, E.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:04 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Cancer Reconstruction of Head & Neck, General Rhinology, Surgery, Surgical Interventions, Endoscopy/ Minimally Invasive Surgery, Facial Plastic Surgery, Reconstructive Facial Surgery]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.135</dc:identifier>
<dc:title><![CDATA[A New Surgical Method of Dynamic Nasal Valve Collapse [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>1014</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1010</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/1015?rss=1">
<title><![CDATA[Decompression of the Orbital Apex: An Alternate Approach to Surgical Excision for Radiographically Benign Orbital Apex Tumors [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/1015?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To study the outcome of patients with orbital apex lesions treated with endoscopic decompression alone.</p>
<p><b>Design&nbsp;</b> Retrospective medical chart review with a mean follow-up of 25.6 months.</p>
<p><b>Setting&nbsp;</b> Departments of Ophthalmology and Otolaryngology, University of Washington, Seattle.</p>
<p><b>Patients&nbsp;</b> Five individuals seen at the University of Washington Medical Center from November 2003 through December 2005 with visual disturbance caused by orbital apex lesions as documented by preoperative magnetic resonance imaging or computed tomographic scan.</p>
<p><b>Intervention&nbsp;</b> All patients underwent endoscopic decompression of the medial wall of the orbital apex with incision of the periorbita.</p>
<p><b>Main Outcome Measures&nbsp;</b> Postoperative visual acuity, presence or absence of a relative afferent pupillary defect, color vision, and visual field were recorded.</p>
<p><b>Results&nbsp;</b> All 5 patients presented with visual field deficits, 4 of whom improved postoperatively. Three patients had dyschromatopsia preoperatively, 2 of whom improved postoperatively. Visual acuity improved or stabilized in 4 of 5 patients postoperatively. One patient had progressive visual loss during the course of her follow-up, which, after obtaining postoperative imaging, was attributed to inadequate decompression of the apex at its most posterior aspect. This same patient also developed postoperative sinusitis that resolved with antibiotic treatment. Two patients developed diplopia, 1 in primary gaze requiring treatment with prismatic lenses. All patients presented with and maintained normal intraocular pressures.</p>
<p><b>Conclusion&nbsp;</b> Orbital apex lesions can often be effectively and relatively safely treated by endoscopic decompression alone.</p>
]]></description>
<dc:creator><![CDATA[Almond, M. C., Cheng, A. G., Schiedler, V., Sires, B. S., Most, S. P., Jian-Amadi, A.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:04 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Ophthalmology, Ophthalmological Disorders, Ocular/ Adnexal Tumors, Otolaryngology/ Head & Neck Surgery, Neoplasms of Head & Neck, Surgery, Surgical Interventions, Endoscopy/ Minimally Invasive Surgery, Surgical Oncology]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.147</dc:identifier>
<dc:title><![CDATA[Decompression of the Orbital Apex: An Alternate Approach to Surgical Excision for Radiographically Benign Orbital Apex Tumors [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>1018</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1015</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/1019?rss=1">
<title><![CDATA[The Role of Pectoralis Major Muscle Flap in Salvage Total Laryngectomy [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/1019?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To assess the utility of the pectoralis major muscle flap (PMMF) in patients undergoing salvage total laryngectomy.</p>
<p><b>Design&nbsp;</b> Retrospective cohort analysis.</p>
<p><b>Setting&nbsp;</b> Tertiary care cancer center.</p>
<p><b>Patients&nbsp;</b> The study included 461 patients who underwent laryngectomy. Eighty of them underwent salvage surgery with primary pharyngeal closure.</p>
<p><b>Interventions&nbsp;</b> Of the 80 patients, 69 (86%) underwent primary pharyngeal closure alone and 11 (14%) underwent a PMMF, which was used to buttress the pharyngeal suture line.</p>
<p><b>Main Outcome Measure&nbsp;</b> Two hundred thirty-six variables were recorded for each patient. Complications related to pharyngeal closure were measured.</p>
<p><b>Results&nbsp;</b> Sixty-four percent of the patients who underwent PMMF also underwent chemoradiation therapy as the initial definitive treatment compared with 25% in the non-PMMF group (<I>P</I>&nbsp;=&nbsp;.03). On multivariate analysis, chemoradiation therapy was the only independent predictor of pharyngocutaneous fistula formation (relative risk, 1.82; <I>P</I>&nbsp;=&nbsp;.02). Nevertheless, the pharyngocutaneous fistula rate was similar in the PMMF (27%) and the non-PMMF (24%) groups. Furthermore, similar durations of tube feeding, days to oral feeding, and hospitalization period were recorded in both groups.</p>
<p><b>Conclusion&nbsp;</b> The PMMF should be used judiciously as a surgical adjunct in high-risk patients, with the goal of minimizing the risk for the development of a pharyngocutaneous fistula.</p>
]]></description>
<dc:creator><![CDATA[Gil, Z., Gupta, A., Kummer, B., Cordeiro, P. G., Kraus, D. H., Shah, J. P., Patel, S. G.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:04 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Laryngology/ Speech/ Language Pathology, Neoplasms of Head & Neck, Surgery, Surgical Interventions, Surgical Oncology, Facial Plastic Surgery, Reconstructive Facial Surgery]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.126</dc:identifier>
<dc:title><![CDATA[The Role of Pectoralis Major Muscle Flap in Salvage Total Laryngectomy [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>1023</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1019</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/1024?rss=1">
<title><![CDATA[Metastatic Carcinoma of the Neck of Unknown Primary Origin: Evolution and Efficacy of the Modern Workup [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/1024?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To assess the efficacy of various diagnostic modalities in detecting occult primary tumor location.</p>
<p><b>Design&nbsp;</b> Retrospective medical record study.</p>
<p><b>Setting&nbsp;</b> Academic head and neck oncology practice.</p>
<p><b>Patients&nbsp;</b> A total of 183 consecutive patients with metastatic carcinoma of the neck from an unknown primary tumor during a 10-year period, after exclusion of those with previous history of head and neck cancer, a primary tumor site evident on physical examination, or primary tumors of the neck.</p>
<p><b>Main Outcome Measures&nbsp;</b> Identification of primary tumor location by various imaging modalities and panendoscopy with directed biopsies.</p>
<p><b>Results&nbsp;</b> Primary tumor location was identified in 84 patients (45.9%). Preoperative imaging (computed tomography [CT], magnetic resonance imaging, positron emission tomography [PET], and/or PET-CT fusion scan) identified sites suggestive of primary tumor location in 69 patients. Subsequent directed biopsy of these sites yielded positive results in 42 cases (60.9%). The rate of successful identification of a primary tumor for each of the imaging modalities was as follows: CT scan of the neck, 14 of 146 patients (9.6%); magnetic resonance imaging of the neck, 0 of 13 patients (0%); whole-body PET scan, 6 of 41 patients (14.6%); and PET-CT fusion study, 23 of 52 patients (44.2%) (<I>P</I>&nbsp;=&nbsp;.001). The highest yield in identifying primary tumor sites was obtained in patients who had undergone PET-CT plus panendoscopy with directed biopsies with or without tonsillectomy: 31 of 52 patients (59.6%).</p>
<p><b>Conclusion&nbsp;</b> Diagnostic workup including PET-CT, alongside panendoscopy with directed biopsies including bilateral tonsillectomy, offers the greatest likelihood of successfully identifying occult primary tumor location.</p>
]]></description>
<dc:creator><![CDATA[Waltonen, J. D., Ozer, E., Hall, N. C., Schuller, D. E., Agrawal, A.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:04 PDT</dc:date>
<dc:subject><![CDATA[Functional Imaging, Oncology, Head & Neck Cancer, Oncology, Other, Otolaryngology/ Head & Neck Surgery, Endoscopy of Upper Aerodigestive Tract, Neoplasms of Head & Neck, Otolaryngology/ Head & Neck Surgery, Other, Radiologic Imaging, Surgery, Surgical Interventions, Endoscopy/ Minimally Invasive Surgery, Diagnosis, Magnetic Resonance Imaging, PET/ SPECT Imaging]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.145</dc:identifier>
<dc:title><![CDATA[Metastatic Carcinoma of the Neck of Unknown Primary Origin: Evolution and Efficacy of the Modern Workup [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>1029</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1024</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/1030?rss=1">
<title><![CDATA[Salvage Treatment of Late Neck Metastasis in Esthesioneuroblastoma: A Meta-analysis [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/1030?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> Esthesioneuroblastoma (ENB) is an uncommon tumor of the sinonasal region with a 20% rate of neck metastases. To our knowledge, the rate of neck metastases occurring 6 or more months after diagnosis has not been well characterized. The rate of successful salvage of these late neck metastases, defined in this study as disease-free survival for at least 1 year, has not been previously reported.</p>
<p><b>Design&nbsp;</b> Meta-analysis examining 33 articles published since 1990.</p>
<p><b>Patients&nbsp;</b> A total of 678 patients with ENB with 79 patients with neck metastases occurring 6 or more months after the initial diagnosis.</p>
<p><b>Interventions&nbsp;</b> Patients were grouped according to treatment with surgery, radiotherapy, or combined surgery and radiotherapy.</p>
<p><b>Main Outcome Measures&nbsp;</b> The rate of successful salvage of late neck metastases, defined as disease-free survival for at least 1 year, was compared for the 3 treatment groups.</p>
<p><b>Results&nbsp;</b> The rate of cervical metastases was 20.2%, with a 12.4% rate of late neck metastases. The combined successful salvage rate for late neck metastases with surgery, radiation, or combined therapy was 31.2%. An odds ratio (OR) analysis revealed that surgery plus radiation provided a statistically significant increase in the rate of successful salvage in patients with late neck metastases, with an OR of 8.6 vs single modality therapy and a number-needed-to-treat of 3. We found no difference in the OR for successful salvage for surgery alone vs radiation alone (OR, 1.5).</p>
<p><b>Conclusion&nbsp;</b> Treatment of neck metastases occurring 6 or more months after an initial diagnosis of ENB with combined surgery and radiotherapy provides a statistically significant survival advantage vs single-modality therapy.</p>
]]></description>
<dc:creator><![CDATA[Gore, M. R., Zanation, A. M.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:04 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Oncology, Other, Otolaryngology/ Head & Neck Surgery, Neoplasms of Head & Neck, Quality of Care, Evidence-Based Medicine, Radiation Therapy, Surgery, Surgical Interventions, Surgical Oncology]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.143</dc:identifier>
<dc:title><![CDATA[Salvage Treatment of Late Neck Metastasis in Esthesioneuroblastoma: A Meta-analysis [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>1034</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1030</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/1035?rss=1">
<title><![CDATA[Reduced {gamma}-Catenin Expression and Poor Survival in Oral Squamous Cell Carcinoma [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/1035?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To investigate whether reduced expression of -, &beta;-, or -catenin predicts poor survival in oral squamous cell carcinoma (OSCC).</p>
<p><b>Design&nbsp;</b> Immunohistochemical analyses of a retrospective cohort.</p>
<p><b>Setting&nbsp;</b> University-affiliated hospital.</p>
<p><b>Patients&nbsp;</b> One hundred twenty-four patients with OSCC.</p>
<p><b>Main Outcome Measure&nbsp;</b> The prognostic value of -catenin expression on disease-specific survival in different T and N category groups in patients with OSCC.</p>
<p><b>Results&nbsp;</b> Reduced expression of -catenin correlated with poor tumor differentiation of OSCC (<I>P</I>&nbsp;=&nbsp;.04). Patients with reduced -catenin expression in the primary tumor had significantly more frequent lymph node metastasis than did patients with normal -catenin expression (<I>P</I>&nbsp;=&nbsp;. 03). Reduced expression of -catenin (004) but not of -catenin (<I>P</I>&nbsp;=&nbsp;.25) or &beta;-catenin (<I>P</I>&nbsp;=&nbsp;.48) correlated with poor clinical outcome. Reduced -catenin expression predicted poor disease-specific survival also in the 92 patients with T1 or T2 tumors (<I>P</I>&nbsp;=&nbsp;. 02). In multivariate analysis, advanced T category (<I>P</I>&nbsp;=&nbsp;. 04), neck lymph node metastases (<I>P</I>&nbsp;=&nbsp;. 01), and reduced -catenin expression (<I>P</I>&nbsp;=&nbsp;. 05) were independently related to poor survival.</p>
<p><b>Conclusions&nbsp;</b> Reduced expression of -catenin was associated with poor differentiation of OSCC, with neck lymph node metastases, and, more importantly, with poor disease-specific survival. Loss of -catenin expression seems to contribute to metastatic properties of OSCC. Evaluation of the expression pattern of -catenin may be useful for predicting outcome in patients with OSCC.</p>
]]></description>
<dc:creator><![CDATA[Narkio-Makela, M., Pukkila, M., Lagerstedt, E., Virtaniemi, J., Pirinen, R., Johansson, R., Kosunen, A., Lappalainen, K., Hamalainen, K., Kosma, V.-M.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:04 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Dentistry/ Oral Medicine, Otolaryngology/ Head & Neck Surgery, Neoplasms of Head & Neck, Prognosis/ Outcomes]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.132</dc:identifier>
<dc:title><![CDATA[Reduced {gamma}-Catenin Expression and Poor Survival in Oral Squamous Cell Carcinoma [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>1040</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1035</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/1041?rss=1">
<title><![CDATA[Geriatric Thyroidectomy: Safety of Thyroid Surgery in an Aging Population [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/1041?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To ascertain whether there are incremental risks associated with thyroid surgery in the elderly population.</p>
<p><b>Design&nbsp;</b> Prospective analysis of a consecutive single-surgeon series of patients undergoing thyroid surgery at an academic health center.</p>
<p><b>Setting&nbsp;</b> Tertiary care health center.</p>
<p><b>Patients&nbsp;</b> The study included patients aged 21 to 35 years and patients 65 years and older who underwent thyroidectomy.</p>
<p><b>Main Outcome Measures&nbsp;</b> Pathology reports, complications (including rates of temporary and permanent hypocalcemia and temporary and permanent true vocal fold [TVF] paralysis), and need for admission or readmission were included in the analysis.</p>
<p><b>Results&nbsp;</b> There were 86 youthful patients who underwent thyroidectomy between November 2003 and December of 2007; 44 elderly patients underwent surgery during that same time frame. There were no deaths in either cohort, no hematomas, and no cases of permanent TVF paralysis. The elderly patients had a similar rate of complications when compared with the youthful patients, including transient hypocalcemia (12.5% vs 11.1%, respectively) and temporary TVF paresis (2.9% vs 3.9%), but a higher rate of readmission (4.5% vs 1.2%, <I>P</I>&nbsp;=&nbsp;.26).</p>
<p><b>Conclusions&nbsp;</b> Thyroid surgeons will be faced more often with the prospect of elective thyroid surgery in patients of advanced age as an increasingly aged population emerges and the prevalence of thyroid nodules and thyroid cancer increases. Thyroid surgery in elderly patients is safe and no more dangerous than surgery in youthful patients. There is a slightly higher rate of readmission.</p>
]]></description>
<dc:creator><![CDATA[Seybt, M. W., Khichi, S., Terris, D. J.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:04 PDT</dc:date>
<dc:subject><![CDATA[Aging/ Geriatrics, Otolaryngology/ Head & Neck Surgery, Endocrine Disease of Head & Neck, Surgery, Surgical Interventions, Endocrine Surgery, Prognosis/ Outcomes, Endocrine Diseases, Thyroid/ Parathyroid Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.138</dc:identifier>
<dc:title><![CDATA[Geriatric Thyroidectomy: Safety of Thyroid Surgery in an Aging Population [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>1044</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1041</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/1045?rss=1">
<title><![CDATA[Branchial Cleft Cyst Causing Carotid Sinus Syndrome [Clinical Note]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/1045?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Alexander, A. A. Z., Groblewski, J. C., Davidson, B. J.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:04 PDT</dc:date>
<dc:subject><![CDATA[Cardiovascular System, Other, Otolaryngology/ Head & Neck Surgery, Congenital Anomalies of Head & Neck, Congenital Malformations, Cardiovascular System]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.129</dc:identifier>
<dc:title><![CDATA[Branchial Cleft Cyst Causing Carotid Sinus Syndrome [Clinical Note]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>1047</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1045</prism:startingPage>
<prism:section>Clinical Note</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/1048?rss=1">
<title><![CDATA[Narrow Duplicated Internal Auditory Canal: A Rare Inner Ear Malformation With Sensorineural Hearing Loss [Clinical Note]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/1048?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Kono, T., Kuwashima, S., Arakawa, H., Yamazaki, E., Kitajima, K., Ejima, Y., Ishikawa, T., Hashimoto, T., Kaji, Y.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:04 PDT</dc:date>
<dc:subject><![CDATA[Neurology, Neuro-otology, Otolaryngology/ Head & Neck Surgery, Congenital Anomalies of Head & Neck, Hearing Loss/ Deafness, Pediatric Otolaryngology, Pediatrics, Congenital Malformations]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.137</dc:identifier>
<dc:title><![CDATA[Narrow Duplicated Internal Auditory Canal: A Rare Inner Ear Malformation With Sensorineural Hearing Loss [Clinical Note]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>1051</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1048</prism:startingPage>
<prism:section>Clinical Note</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/1052?rss=1">
<title><![CDATA[Radiology Quiz Case 1 [Clinical Problem Solving: Radiology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/1052?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Rao, V., Arya, S., Juvekar, S., Chaukar, D., D'cruz, A. K.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:04 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Otolaryngology/ Head & Neck Surgery, Neoplasms of Head & Neck, Radiology of Head & Neck, Diagnosis]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.127-a</dc:identifier>
<dc:title><![CDATA[Radiology Quiz Case 1 [Clinical Problem Solving: Radiology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>1052</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1052</prism:startingPage>
<prism:section>Clinical Problem Solving: Radiology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/1053?rss=1">
<title><![CDATA[Radiology Quiz Case 2 [Clinical Problem Solving: Radiology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/1053?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[de Villiers, L., Som, P. M.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:04 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Airway Obstruction, Radiology of Head & Neck, Otolaryngology/ Head & Neck Surgery, Other, Radiologic Imaging, Diagnosis, Computed Tomography]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.128-a</dc:identifier>
<dc:title><![CDATA[Radiology Quiz Case 2 [Clinical Problem Solving: Radiology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>1053</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1053</prism:startingPage>
<prism:section>Clinical Problem Solving: Radiology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/1054?rss=1">
<title><![CDATA[Radiology Quiz Case 1: Diagnosis [Clinical Problem Solving: Radiology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/1054?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:04 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Otolaryngology/ Head & Neck Surgery, Neoplasms of Head & Neck, Radiology of Head & Neck, Diagnosis]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.127-b</dc:identifier>
<dc:title><![CDATA[Radiology Quiz Case 1: Diagnosis [Clinical Problem Solving: Radiology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>1055</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1054</prism:startingPage>
<prism:section>Clinical Problem Solving: Radiology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/1055?rss=1">
<title><![CDATA[Radiology Quiz Case 2: Diagnosis [Clinical Problem Solving: Radiology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/1055?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:04 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Airway Obstruction, Radiology of Head & Neck, Otolaryngology/ Head & Neck Surgery, Other, Radiologic Imaging, Diagnosis, Computed Tomography]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.128-b</dc:identifier>
<dc:title><![CDATA[Radiology Quiz Case 2: Diagnosis [Clinical Problem Solving: Radiology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>1055</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1055</prism:startingPage>
<prism:section>Clinical Problem Solving: Radiology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/1056?rss=1">
<title><![CDATA[Pathology Quiz Case 1 [Clinical Problem Solving: Pathology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/1056?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Groves, M. W., Muller, S., Gathere, S., Gachii, A., Johns, M. M.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:04 PDT</dc:date>
<dc:subject><![CDATA[Infectious Diseases, Other, Ophthalmology, Ophthalmological Disorders, Ophthalmological Disorders, Other, Otolaryngology/ Head & Neck Surgery, Paranasal Sinus Disease, Pathology of Head & Neck, Diagnosis, Infectious Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.124-a</dc:identifier>
<dc:title><![CDATA[Pathology Quiz Case 1 [Clinical Problem Solving: Pathology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>1056</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1056</prism:startingPage>
<prism:section>Clinical Problem Solving: Pathology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/1057?rss=1">
<title><![CDATA[Pathology Quiz Case 2 [Clinical Problem Solving: Pathology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/1057?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Allen, C. T., Hackman, T. G., Lewis, J. S., Haughey, B. H.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:04 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Otolaryngology/ Head & Neck Surgery, Neoplasms of Head & Neck, Pathology of Head & Neck, Diagnosis]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.125-a</dc:identifier>
<dc:title><![CDATA[Pathology Quiz Case 2 [Clinical Problem Solving: Pathology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>1057</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1057</prism:startingPage>
<prism:section>Clinical Problem Solving: Pathology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/1058?rss=1">
<title><![CDATA[Pathology Quiz Case 1: Diagnosis [Clinical Problem Solving: Pathology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/1058?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:04 PDT</dc:date>
<dc:subject><![CDATA[Infectious Diseases, Other, Ophthalmology, Ophthalmological Disorders, Ophthalmological Disorders, Other, Otolaryngology/ Head & Neck Surgery, Paranasal Sinus Disease, Pathology of Head & Neck, Diagnosis, Infectious Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.124-b</dc:identifier>
<dc:title><![CDATA[Pathology Quiz Case 1: Diagnosis [Clinical Problem Solving: Pathology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>1059</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1058</prism:startingPage>
<prism:section>Clinical Problem Solving: Pathology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/10/1059?rss=1">
<title><![CDATA[Pathology Quiz Case 2: Diagnosis [Clinical Problem Solving: Pathology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/10/1059?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 12:52:05 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Otolaryngology/ Head & Neck Surgery, Neoplasms of Head & Neck, Pathology of Head & Neck, Diagnosis]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.125-b</dc:identifier>
<dc:title><![CDATA[Pathology Quiz Case 2: Diagnosis [Clinical Problem Solving: Pathology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>1060</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1059</prism:startingPage>
<prism:section>Clinical Problem Solving: Pathology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/845?rss=1">
<title><![CDATA[Norwegian reflections [About the Cover]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/845?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:28 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Otolaryngology/ Head & Neck Surgery, Other, Humanities]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.142</dc:identifier>
<dc:title><![CDATA[Norwegian reflections [About the Cover]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>845</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>845</prism:startingPage>
<prism:section>About the Cover</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/846?rss=1">
<title><![CDATA[About This Journal [About This Journal]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/846?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:28 PDT</dc:date>
<dc:title><![CDATA[About This Journal [About This Journal]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>846</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>846</prism:startingPage>
<prism:section>About This Journal</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/851?rss=1">
<title><![CDATA[Comparison of Clinical and Pathological Staging in Head and Neck Squamous Cell Carcinoma: Results From Intergroup Study ECOG 4393/RTOG 9614 [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/851?rss=1</link>
<description><![CDATA[
<p><b>Objectives&nbsp;</b> To compare the results of clinical and pathological staging for a large cohort of patients with head and neck squamous cell carcinoma (HNSCC) and to examine patterns and ramifications of the disparity between staging methods.</p>
<p><b>Design&nbsp;</b> Prospective inception cohort (median follow-up, 7 years).</p>
<p><b>Setting&nbsp;</b> Multi-institutional cooperative group study (Eastern Cooperative Oncology Group 4393/Radiation Therapy Oncology Group 9614) involving 17 academic medical centers.</p>
<p><b>Patients&nbsp;</b> A total of 560 patients with new-onset or recurrent HNSCC enrolled during a 7-year period.</p>
<p><b>Interventions&nbsp;</b> Surgical resection with curative intent with or without adjuvant or previous radiotherapy or chemotherapy.</p>
<p><b>Main Outcome Measures&nbsp;</b> Clinical staging and pathological staging and the component TN tumor categories were compared with overall and disease-specific survival. Association of survival with staging was derived by means of the proportional hazards model.</p>
<p><b>Results&nbsp;</b> Of the 501 cases in which both clinical and pathological staging was available, a disparity was found between at least 1 component tumor category assigned by the 2 methods in almost 50% of cases. Both methods showed a strong association of stage with overall survival for the cohort at large. However, pathological nodal category was a superior predictor (<I>P</I>&nbsp;&lt;&nbsp;.001 vs <I>P</I>&nbsp;=&nbsp;.005), whereas there was an advantage to pathological tumor category in predicting disease-specific survival (<I>P</I>&nbsp;=&nbsp;.01).</p>
<p><b>Conclusions&nbsp;</b> Both staging methods are useful in predicting survival, whereas information gained at neck dissection regarding nodal metastases provides some refinement in prognostic results. These findings demonstrate the need for enhanced methods of tumor assessment and apparent benefit of data gathered at neck dissection for accurate disease assessment and stratification.</p>
]]></description>
<dc:creator><![CDATA[Koch, W. M., Ridge, J. A., Forastiere, A., Manola, J.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:28 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Skin Cancer, Otolaryngology/ Head & Neck Surgery, Neoplasms of Head & Neck, Prognosis/ Outcomes]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.123</dc:identifier>
<dc:title><![CDATA[Comparison of Clinical and Pathological Staging in Head and Neck Squamous Cell Carcinoma: Results From Intergroup Study ECOG 4393/RTOG 9614 [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>858</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>851</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/860?rss=1">
<title><![CDATA[Completion of Radiotherapy for Local and Regional Head and Neck Cancer in Medicare [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/860?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To identify factors associated with interruption or early discontinuation of treatment in patients receiving radiotherapy for head and neck cancer, because it is believed that such treatment interruption or early discontinuation increases the risk of disease relapse and adversely influences survival.</p>
<p><b>Design, Setting, and Patients&nbsp;</b> Using the Surveillance, Epidemiology, and End Results (SEER)&ndash;Medicare linked database, we identified Medicare beneficiaries 66 years or older who were diagnosed as having local or regional head and neck cancer from January 1, 1997, through December 31, 2003. For each case, we calculated the timing and duration of radiotherapy using Medicare claims data. We then performed logistic regression analyses to estimate the association between tumor and clinical characteristics and early discontinuation of and/or interruptions in radiotherapy.</p>
<p><b>Main Outcome Measure&nbsp;</b> Completion of uninterrupted radiotherapy.</p>
<p><b>Results&nbsp;</b> A substantial proportion of patients (39.8% overall) had interruptions in radiotherapy and/or incomplete therapy. Altogether, 70.4% of surgical patients completed radiotherapy with no interruptions compared with 52.0% of nonsurgical patients (<sup>2</sup>&nbsp;=&nbsp;78.17; <I>P</I>&nbsp;&lt;&nbsp;.001). Surgery was associated with an increased likelihood of completing uninterrupted radiotherapy for all tumor sites. Comorbidity, chemotherapy, and regional disease were all associated with a decreased likelihood of completing radiotherapy at a subset of sites.</p>
<p><b>Conclusions&nbsp;</b> Failure to complete uninterrupted radiotherapy is common among Medicare enrollees with head and neck cancer. Surgery before radiotherapy is associated with an increased likelihood of completing radiotherapy. At a subset of sites, chemotherapy is associated with a decreased likelihood of completing radiotherapy. Further research is needed to identify factors associated with noncompletion of radiotherapy among nonsurgical patients and patients who receive chemotherapy.</p>
]]></description>
<dc:creator><![CDATA[Fesinmeyer, M. D., Mehta, V., Tock, L., Blough, D., McDermott, C., Ramsey, S. D.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:28 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Oncology, Other, Otolaryngology/ Head & Neck Surgery, Neoplasms of Head & Neck, Patient-Physician Relationship/ Care, Treatment Adherence, Radiation Therapy]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.108</dc:identifier>
<dc:title><![CDATA[Completion of Radiotherapy for Local and Regional Head and Neck Cancer in Medicare [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>867</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>860</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/869?rss=1">
<title><![CDATA[A Phase 2 Trial of Surgery With Perioperative INGN 201 (Ad5CMV-p53) Gene Therapy Followed by Chemoradiotherapy for Advanced, Resectable Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Hypopharynx, and Larynx: Report of the Southwest Oncology Group [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/869?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To assess the feasibility of treating patients with high-risk stage III and IV squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx with perioperative adenovirus-p53 (INGN 201) gene therapy along with surgery and chemoradiotherapy.</p>
<p><b>Design and Setting&nbsp;</b> A phase 2 study in a multi-institutional setting within the Southwest Oncology Group.</p>
<p><b>Patients&nbsp;</b> Thirteen individuals who met the following entry criteria: newly diagnosed, previously untreated squamous cell carcinoma of the oral cavity, oropharynx, larynx, or hypopharynx; selected stage III or IV disease without distant metastases; and surgically resectable disease.</p>
<p><b>Interventions&nbsp;</b> Surgery, perioperative INGN 201 gene therapy, and postoperative chemoradiotherapy.</p>
<p><b>Main Outcome Measures&nbsp;</b> Overall patient status, tumor status, adverse effects, accrual rate, and percentage of patients successfully receiving the required doses of INGN 201.</p>
<p><b>Results&nbsp;</b> All 13 patients received surgery and perioperative INGN 201 injections in the primary tumor bed and the ipsilateral neck. In addition, 3 patients received injections in the contralateral neck. Three patients did not receive chemoradiotherapy. One patient had a grade 2 fistula of the oral cavity. Of the 10 patients with evaluable data, 2 experienced grade 4 adverse events, 1 owing to hypokalemia, hyponatremia, vomiting, leukopenia, and neutropenia and 1 owing to increased aspartate aminotransferase and alanine aminotransferase levels. Seven other patients experienced grade 3 adverse events. The estimate of 1-year progression-free survival is 92%.</p>
<p><b>Conclusions&nbsp;</b> This trial demonstrated the feasibility of handling and delivering a very complex gene vector safely in multiple cooperative group institutions without significant incident. Intraoperative INGN 201 gene therapy is technically feasible, but it has many logistical problems when performed in a multi-institutional setting. Regulatory requirements might have hindered accrual in this multi-institutional setting. Disease control seems to be promising; however, no definitive conclusion can be made with this small sample size.</p>
<p><b>Trial Registration&nbsp;</b> clinicaltrials.gov Identifier: <inter-ref locator-type="url" locator="http://clinicaltrials.gov/ct2/results?term=NCT00017173">NCT00017173</inter-ref></p>
]]></description>
<dc:creator><![CDATA[Yoo, G. H., Moon, J., LeBlanc, M., Lonardo, F., Urba, S., Kim, H., Hanna, E., Tsue, T., Valentino, J., Ensley, J., Wolf, G.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:28 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Otolaryngology/ Head & Neck Surgery, Genetics of Head & Neck Disease, Neoplasms of Head & Neck, Drug Therapy, Drug Therapy, Other, Genetics, Genetic Counseling/ Testing/ Therapy]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.122</dc:identifier>
<dc:title><![CDATA[A Phase 2 Trial of Surgery With Perioperative INGN 201 (Ad5CMV-p53) Gene Therapy Followed by Chemoradiotherapy for Advanced, Resectable Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Hypopharynx, and Larynx: Report of the Southwest Oncology Group [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>874</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>869</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/876?rss=1">
<title><![CDATA[Neck Dissection Planning Based on Postchemoradiation Computed Tomography in Patients With Head and Neck Cancer [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/876?rss=1</link>
<description><![CDATA[
<p><b>Objectives&nbsp;</b> To determine what findings on postchemoradiation (post-CRT) neck computed tomography (CT) may predict removal of the internal jugular vein (IJV) or sternocleidomastoid muscle (SCM) and to examine whether pretreatment CT had any bearing on the ultimate posttreatment neck dissection with regard to the IJV and SCM.</p>
<p><b>Design&nbsp;</b> Retrospective review of CT, intraoperative, and pathologic findings.</p>
<p><b>Setting&nbsp;</b> Tertiary care academic medical center.</p>
<p><b>Patients&nbsp;</b> Thirty-four patients who underwent 43 planned post-CRT hemi-neck dissections for pretreatment N2 or greater disease.</p>
<p><b>Results&nbsp;</b> Of the 43 neck dissections, 39 (91%) were selective neck dissections, 2 (5%) were modified radical dissections, and 2 (5%) were radical neck dissections. The IJV was removed in 6 of the 39 selective neck dissections (15%), in 1 of the 2 modified radical dissections, and in both of the 2 radical neck dissections. The SCM was removed in the 2 modified radical dissections and 2 radical neck dissections. The IJV was removed in 7 of the 9 dissections (78%) in which the IJV was abnormal on preoperative CT (filling defect or thrombosed) vs 2 of the 34 dissections (6%) with a normal IJV on CT (<I>P</I>&nbsp;&lt;&nbsp;.001; positive predictive value, 78%; negative predictive value, 94%). The SCM was removed in 4 of the 11 dissections (36%) in which the tissue plane between the carotid sheath and the SCM was indistinct on CT vs 0 of the 32 dissections with a radiographically normal SCM tissue plane (<I>P</I>&nbsp;=&nbsp;.003; positive predictive value, 36%; negative predictive value, 100%). In 27 patients with pre-CRT CTs for comparison, the IJV normalized in 3 of the 8 patients (38%) with an abnormal IJV on pre-CRT CT, and the tissue plane around the SCM normalized in 15 of the 24 patients (63%) with an indistinct tissue plane on pre-CRT CT.</p>
<p><b>Conclusions&nbsp;</b> Filling defects or thrombosis of the IJV is highly predictive of need for removal intraoperatively, which may affect planning especially in bilateral neck dissections in which an effort may be made to preserve at least 1 vein. Presence of a clear tissue plane between the SCM and carotid sheath predicts the ability to preserve this muscle. Changes in the status of the IJV and SCM seen on CT that occur as a result of CRT may make preservation of these structures more feasible, even in patients with advanced neck disease.</p>
]]></description>
<dc:creator><![CDATA[Langerman, A., Comstock, R., Konda, S., Abramovitch, A., Kasza, K., Vokes, E. E., Stenson, K. M.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:28 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Otolaryngology/ Head & Neck Surgery, Neoplasms of Head & Neck, Radiologic Imaging, Prognosis/ Outcomes, Computed Tomography, Drug Therapy, Drug Therapy, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.119</dc:identifier>
<dc:title><![CDATA[Neck Dissection Planning Based on Postchemoradiation Computed Tomography in Patients With Head and Neck Cancer [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>880</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>876</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/882?rss=1">
<title><![CDATA[Prediction of Simultaneous Esophageal Lesions in Head and Neck Squamous Cell Carcinoma: A Multivariate Analysis [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/882?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To evaluate the frequency of concomitant esophageal lesions detected by esophagoscopy in squamous cell carcinoma (SCC) in the head and neck (HNSCC) and to identify the risk factors.</p>
<p><b>Design&nbsp;</b> Retrospective medical record analysis.</p>
<p><b>Setting&nbsp;</b> Regional hospital.</p>
<p><b>Patients&nbsp;</b> From March 2000 to March 2006, 118 patients with HNSCC had undergone esophagoscopy as part of the disease workup. Three patients had double head and neck primary tumors. Sixty-five patients also underwent chromoendoscopy with Lugol's iodine solution.</p>
<p><b>Main Outcome Measures&nbsp;</b> The incidence of simultaneous esophageal cancer diagnosed on esophagoscopy. Additional esophageal lesions of clinical significance discovered during chromoendoscopy were also evaluated.</p>
<p><b>Results&nbsp;</b> Clinically important esophageal lesions were found in 12 patients (10%)&mdash;9 carcinomas and 3 dysplastic lesions. Chromoendoscopy was useful in 5 of these 12 cases, detecting 3 dysplastic lesions not visualized by ordinary esophagogastroduodenoscopy and additional lesions in 2 patients with esophageal carcinoma. Of the patients in whom isolated oral cavity SCC was considered, the incidence of synchronous esophageal lesions was only 1.5%. Sex (<I>P</I>&nbsp;=&nbsp;.02), younger age (<I>P</I>&nbsp;=&nbsp;.04), alcohol drinking (<I>P</I>&nbsp;=&nbsp;.047), and tumor sites (<I>P</I>&nbsp;=&nbsp;.002) were significant predictors of synchronous esophageal lesions on univariate analysis. On multivariate analysis, only tumor site remained a significant risk factor (<I>P</I>&nbsp;=&nbsp;.009).</p>
<p><b>Conclusions&nbsp;</b> Clinically important esophageal lesions rarely coexists with oral cavity SCC, for which the benefit of routine esophagogastroduodenoscopy is questionable. Chromoendoscopy enhances the identification of early but clinically important esophageal abnormalities if esophagoscopy is performed for SCC in the larynx, hypopharynx, and oropharynx.</p>
]]></description>
<dc:creator><![CDATA[Chow, T.-L., Lee, D. T.-Y., Choi, C.-Y., Chan, T. T.-F., Lam, S.-H.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:28 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Dentistry/ Oral Medicine, Otolaryngology/ Head & Neck Surgery, Neoplasms of Head & Neck, Diagnosis, Gastroenterology, Gastrointestinal Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.105</dc:identifier>
<dc:title><![CDATA[Prediction of Simultaneous Esophageal Lesions in Head and Neck Squamous Cell Carcinoma: A Multivariate Analysis [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>885</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>882</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/887?rss=1">
<title><![CDATA[Oropharyngoplasty With Template-Based Reconstruction of Oropharynx Defects [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/887?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To determine if oropharyngoplasty using a Gehanno technique of superior constrictor velopharyngoplasty, base of tongue mounding, and primary hypopharyngeal closure in combination with template-based revascularized free tissue transfer is effective for reconstruction of the oropharyngeal defect.</p>
<p><b>Design&nbsp;</b> Prospective case series.</p>
<p><b>Setting&nbsp;</b> Tertiary care academic medical center.</p>
<p><b>Patients&nbsp;</b> The study population comprised 25 patients (21 men and 4 women; mean age, 55.3 years) presenting from January 1998 to January 2001 with oropharyngeal squamous cell carcinoma. A comparison was performed based on the percentage of resection of the soft palate (group 1, &le;50% palate; group 2, >50% palate).</p>
<p><b>Interventions&nbsp;</b> Of the 25 patients, 24 (96%) received radiotherapy. The donor sites were radial forearm for 23 of 25 patients (92%) and lateral arm for 2 of 25 patients (8%). The mean area was 92 cm<sup>2</sup> (range, 25-150 cm<sup>2</sup>), and the mean length of the velopharyngoplasty component of the oropharyngoplasty was 2.15 cm (range, 1-3 cm).</p>
<p><b>Main Outcome Measures&nbsp;</b> Gastrostomy tube dependence, major and minor complications, time to oral intake, speech and swallowing assessment, and quality-of-life assessment.</p>
<p><b>Results&nbsp;</b> Of the 25 patients, 2 (8%) remain gastrostomy dependent; 6 (24%) developed major complications; and 7 (28%) developed minor complications. Speech in both groups 1 and 2 was considered understandable most of the time, with occasional repetition. The group 1 patient with a median assessment score could eat a solid diet without restriction of place or person, whereas the group 2 patient with a median assessment score could eat a soft, moist diet with selected persons in selected places.</p>
<p><b>Conclusion&nbsp;</b> Integration of oropharyngoplasty with template-based revascularized free tissue transfer produced speech results that were independent of palate defect size, and swallow function test results were similar to other published reconstructive techniques.</p>
]]></description>
<dc:creator><![CDATA[Chepeha, D. B., Sacco, A. G., Erickson, V. R., Lyden, T., Haxer, M., Moyer, J., Teknos, T. N., Prince, M. E., Eisbruch, A., Bradford, C. R., Wolf, G. T.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:29 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Otolaryngology/ Head & Neck Surgery, Cancer Reconstruction of Head & Neck, Dysphagia, Laryngology/ Speech/ Language Pathology, Neoplasms of Head & Neck, Prognosis/ Outcomes]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.130</dc:identifier>
<dc:title><![CDATA[Oropharyngoplasty With Template-Based Reconstruction of Oropharynx Defects [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>894</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>887</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/896?rss=1">
<title><![CDATA[Expression of Fibroblast Growth Factor Binding Protein in Head and Neck Cancer [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/896?rss=1</link>
<description><![CDATA[
<p><b>Objectives&nbsp;</b> To characterize the expression of fibroblast growth factor binding protein (FGF-BP) messenger RNA (mRNA) in head and neck squamous cell carcinoma (HNSCC) and to study the association of FGF-BP with vascularity.</p>
<p><b>Design&nbsp;</b> The expression of FGF-BP mRNA in HNSCC was studied in 35 primary and 8 metastatic HNSCC specimens and 7 control tissues using in situ hybridization and reverse transcriptase&ndash;polymerase chain reaction (RT-PCR). Microvessels in tumor specimens were identified with endothelial cell markers (von Willebrand factor [vWF] and CD34-specific antibodies). Correlates between FGF-BP and microvessel counts were evaluated statistically.</p>
<p><b>Setting&nbsp;</b> University of Minnesota Hospitals and Clinics.</p>
<p><b>Patients&nbsp;</b> Forty-two surgically treated patients with HNSCC.</p>
<p><b>Interventions&nbsp;</b> The patients were routinely treated in the study hospitals and clinics.</p>
<p><b>Main Outcome Measures&nbsp;</b> The expression of FGF-BP and angiogenesis in tumors were evaluated.</p>
<p><b>Results&nbsp;</b> In situ hybridization and RT-PCR demonstrated that FGF-BP mRNA transcripts were expressed in 34 of 35 primary HNSCC specimens and 5 of 8 metastatic tumor specimens but not in adjacent control tissues. The microvessel counts in HNSCC specimens were closely related to the expression level of FGF-BP (<I>P</I>&nbsp;&lt;&nbsp;.001).</p>
<p><b>Conclusion&nbsp;</b> The expression of FGF-BP is statistically linked to the angiogenesis of HNSCC, suggesting that FGF-BP participates in the angiogenesis of HNSCC.</p>
]]></description>
<dc:creator><![CDATA[Li, W., Wang, C., Juhn, S. K., Ondrey, F. G., Lin, J.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:29 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Skin Cancer, Otolaryngology/ Head & Neck Surgery, Neoplasms of Head & Neck]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.121</dc:identifier>
<dc:title><![CDATA[Expression of Fibroblast Growth Factor Binding Protein in Head and Neck Cancer [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>901</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>896</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/903?rss=1">
<title><![CDATA[Bilateral Cochlear Implantation in Children With Anomalous Cochleovestibular Anatomy [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/903?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To outline clinical experience with bilateral cochlear implantation in children with cochleovestibular anomalies.</p>
<p><b>Design&nbsp;</b> A prospective cohort study with a mean follow-up of 12 months.</p>
<p><b>Setting&nbsp;</b> An academic, pediatric, tertiary referral center.</p>
<p><b>Patients&nbsp;</b> All eligible children were prospectively recruited from January 1, 2007, through October 31, 2008. Ten children aged 9 to 33 months who had congenital inner ear malformations, including common cavity, incomplete partition, and cochleovestibular hypoplasia, participated.</p>
<p><b>Interventions&nbsp;</b> Bilateral cochlear implantation was performed sequentially with an interimplantation delay greater than 2 years in 7 children and less than 1 year in 1 child. Bilateral simultaneous implantation was performed in 2 children.</p>
<p><b>Main Outcome Measures&nbsp;</b> Complications, hearing outcomes, and balance outcomes.</p>
<p><b>Results&nbsp;</b> All children underwent successful implantation. Five children had a perilymph "gusher" (on 1 side only), and there were no other complications. All children had 22 active electrodes bilaterally and achieved speech reception. All 8 children who underwent closed-set speech perception testing scored above 75%, and 5 of the 7 children who underwent open-set testing achieved scores above 75%. Despite variable vestibular function before bilateral implantation, no prolonged imbalance occurred, although 3 children (30%) had transient unsteadiness for up to 2 weeks after the second implantation.</p>
<p><b>Conclusions&nbsp;</b> Bilateral cochlear implantation was performed safely and successfully in children with a spectrum of bilaterally anomalous cochleovestibular anatomy. Hearing outcomes suggest that these children should not be excluded from undergoing bilateral implantation. This study provides guidance on candidacy issues, surgical decision making, and surgical techniques in this group.</p>
]]></description>
<dc:creator><![CDATA[Chadha, N. K., James, A. L., Gordon, K. A., Blaser, S., Papsin, B. C.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:29 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Cochlear Implantation, Hearing Loss/ Deafness, Pediatric Otolaryngology, Pediatrics, Congenital Malformations]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.120</dc:identifier>
<dc:title><![CDATA[Bilateral Cochlear Implantation in Children With Anomalous Cochleovestibular Anatomy [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>909</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>903</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/910?rss=1">
<title><![CDATA[An Investigation of Upper Airway Changes Associated With Mandibular Advancement Device Using Sleep Videofluoroscopy in Patients With Obstructive Sleep Apnea [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/910?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To quantitatively evaluate the effects of the mandibular advancement device (MAD) on changes in the upper respiratory tract during sleep using sleep videofluoroscopy (SVF) in patients with obstructive sleep apnea (OSA).</p>
<p><b>Design&nbsp;</b> Retrospective analysis.</p>
<p><b>Setting&nbsp;</b> Academic tertiary referral center.</p>
<p><b>Patients&nbsp;</b> Seventy-six patients (68 men and 8 women) who were treated with the MAD for OSA were included from September 1, 2005, through August 31, 2008.</p>
<p><b>Intervention&nbsp;</b> All patients underwent nocturnal polysomnography and SVF before and at least 3 months after receipt of the custom-made MAD. Sleep videofluoroscopy was performed before and after sleep induction and was analyzed during 3 states of awakeness, normoxygenation sleep, and desaturation sleep.</p>
<p><b>Main Outcome Measures&nbsp;</b> Changes in the length of the soft palate, retropalatal space, retrolingual space, and angle of mouth opening were evaluated during sleep events with or without the MAD.</p>
<p><b>Results&nbsp;</b> Without the MAD, the length of the soft palate and the angle of mouth opening increased during sleep events, especially in desaturation sleep, compared with the awake state. The retropalatal space and retrolingual space became much narrower during sleep compared with the awake state. The MAD had marked effects on the length of the soft palate, retropalatal space, retrolingual space, and angle of mouth opening. The retropalatal space and retrolingual space were widened, and the length of the soft palate was decreased. The MAD kept the mouth closed.</p>
<p><b>Conclusions&nbsp;</b> Sleep videofluoroscopy showed dynamic upper airway changes in patients with OSA, and the MAD exerted multiple effects on the size and configuration of the airway. Sleep videofluoroscopy demonstrated the mechanism of action of the MAD in patients with OSA. The MAD increased the retropalatal and retrolingual spaces and decreased the length of the soft palate and the angle of mouth opening, resulting in improvement of OSA.</p>
]]></description>
<dc:creator><![CDATA[Lee, C. H., Kim, J.-W., Lee, H. J., Yun, P.-Y., Kim, D.-Y., Seo, B. S., Yoon, I.-Y., Mo, J.-H.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:29 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Sleep Apnea]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.112</dc:identifier>
<dc:title><![CDATA[An Investigation of Upper Airway Changes Associated With Mandibular Advancement Device Using Sleep Videofluoroscopy in Patients With Obstructive Sleep Apnea [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>914</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>910</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/915?rss=1">
<title><![CDATA[First-Choice Treatment in Mild to Moderate Obstructive Sleep Apnea: Single-Stage, Multilevel, Temperature-Controlled Radiofrequency Tissue Volume Reduction or Nasal Continuous Positive Airway Pressure [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/915?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To compare the efficacy of single-stage, multilevel, temperature-controlled radiofrequency tissue volume reduction (TCRFTVR) for the soft palate and base of the tongue with that of nasal continuous positive airway pressure (CPAP) in primary treatment of mild to moderate obstructive sleep apnea.</p>
<p><b>Design&nbsp;</b> A prospective nonrandomized clinical study.</p>
<p><b>Setting&nbsp;</b> Tertiary care referral center.</p>
<p><b>Patients&nbsp;</b> Data from 47 patients with mild to moderate obstructive sleep apnea treated between January 1, 2003, and October 31, 2006, were reviewed.</p>
<p><b>Interventions&nbsp;</b> Twenty-six patients underwent TCRFTVR and 21 underwent nasal CPAP as a primary treatment modality.</p>
<p><b>Main Outcome Measures&nbsp;</b> Baseline and 12-month posttreatment measurements using the Epworth Sleepiness Scale and polysomnography were compared.</p>
<p><b>Results&nbsp;</b> The baseline characteristics of the groups were not significantly different. Both methods showed meaningful results for the Epworth Sleepiness Scale and polysomnography variables 12 months after treatment compared with baseline measurements. The results were not significantly different in the posttreatment intergroup comparisons. Treatment success rates were 52.4% for nasal CPAP and 53.8% for TCRFTVR (<I>P</I>&nbsp;=&nbsp;.92).</p>
<p><b>Conclusion&nbsp;</b> Similar comparison results with nasal CPAP in objective and subjective variables make single-stage, multilevel TCRFTVR a good alternative in primary treatment of mild to moderate obstructive sleep apnea.</p>
]]></description>
<dc:creator><![CDATA[Ceylan, K., Emir, H., Kizilkaya, Z., Tastan, E., Yavanoglu, A., Uzunkulaoglu, H., Samim, E., Felek, S. A.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:29 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Sleep Apnea]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.117</dc:identifier>
<dc:title><![CDATA[First-Choice Treatment in Mild to Moderate Obstructive Sleep Apnea: Single-Stage, Multilevel, Temperature-Controlled Radiofrequency Tissue Volume Reduction or Nasal Continuous Positive Airway Pressure [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>919</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>915</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/920?rss=1">
<title><![CDATA[Mandibular Thickness Measurements in Young Dentate Adults [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/920?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To measure thicknesses in clinical landmark areas of the dentate mandibles of young men and women.</p>
<p><b>Design&nbsp;</b> Using standard radiologic software, we obtained mean (SD) thickness measurements at the inferior or posterior borders of the mandible at the following 7 surgically useful sites: (1) the symphysis, (2) a point halfway between the symphysis and the mental nerve, (3) the mental nerve, (4) a point halfway between the mental nerve and the facial artery notch, (5) the facial artery notch, (6) the angle vertex, and (7) the ramus&ndash;condylar neck border.</p>
<p><b>Setting&nbsp;</b> University hospital.</p>
<p><b>Patients&nbsp;</b> A total of 150 dentate men and 75 dentate women aged 18 to 30 years who had undergone computed tomography of the head and neck region during the period of December 20, 2006 to February 20, 2007.</p>
<p><b>Main Outcome Measure&nbsp;</b> Thicknesses of 7 mandibular sites.<b></b></p>
<p><b>Results&nbsp;</b> Mean (SD) thicknesses at the 7 mandibular sites were as follows: symphysis, 14.03&nbsp;(1.53) mm for men and 13.21 (1.46) mm for women; halfway between the symphysis and the mental nerve, 11.17 (1.37) mm for men and 10.00 (1.08) mm for women; mental nerve, 9.48 (1.28) mm for men and 8.72&nbsp;(1.00) mm for women; halfway between the mental nerve and the facial artery notch, 10.33 (1.24) mm for men and 9.45 (0.92) mm for women; facial artery notch, 7.27 (0.82) mm for men and 7.10 (0.88) mm for women; angle vertex, 5.42 (0.90) mm for men and 5.39 (0.66) mm for women; and ramus&ndash;condylar neck border, 5.90 (0.86) mm for men and 5.85 (0.71) mm for women.</p>
<p><b>Conclusions&nbsp;</b> Clinical landmark areas in young dentate mandibles have mean thicknesses with limited SDs. The thickness measurements obtained at the sites in this study provide practical reference information for mandibular reconstruction and bicortical screw length estimation.</p>
]]></description>
<dc:creator><![CDATA[Beaty, N. B., Le, T. T.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:29 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Oral/ Maxillofacial Trauma, Facial Plastic Surgery, Reconstructive Facial Surgery, Trauma/ Maxillofacial Surgery]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.109</dc:identifier>
<dc:title><![CDATA[Mandibular Thickness Measurements in Young Dentate Adults [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>923</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>920</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/924?rss=1">
<title><![CDATA[Surgical Management of Drooling: A Meta-analysis [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/924?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To review and assess the current published literature regarding the efficacy of surgical management of sialorrhea in pediatric patients.</p>
<p><b>Data Sources&nbsp;</b> The MEDLINE database was systematically reviewed for articles reporting on the use of surgical procedures to treat sialorrhea published from January 1, 1963, to November 30, 2008.</p>
<p><b>Study Selection&nbsp;</b> Inclusion criteria included presence of data on the success of surgical treatment of sialorrhea, English language, sample size greater than 5, and presentation of extractable data regarding the subjective success of surgical management of sialorrhea.</p>
<p><b>Data Extraction&nbsp;</b> Data regarding demographic characteristics of study participants, follow-up duration, subjective success rates, and number and type of complications were extracted by blinded reviewers.</p>
<p><b>Data Synthesis&nbsp;</b> A total of 325 studies were identified on initial search. Abstract review reduced the sample to 46. Cross-referencing yielded an additional 4 articles, resulting in the final sample of 50 articles. Forty-seven studies were case series (Centre for Evidence-Based Medicine level 4 evidence), 2 were cohort studies (level 2), and 1 was a prospective cohort study (level 1b). Median sample size was 18 (range, 5-181), and median follow-up duration was 8.1 months (range,&nbsp;0.1-50 months). Subjective success was reported in more than 50% of patients in 49 of 50 studies. Random-effects modeling estimated the overall subjective success rate for all procedures to be 81.6% (95% confidence interval,&nbsp;77.5%-85.7%; <I>P</I>&nbsp;&lt;&nbsp;.001). Bilateral submandibular gland excision and parotid duct rerouting appeared to have the highest subjective success rates at 87.8% (k&nbsp;=&nbsp;8 studies; 95% confidence interval,&nbsp;80.5%-95.1%; <I>P</I>&nbsp;&lt;.001), and 4-duct ligation was the lowest at 64.1% (4 studies; 27.6%-100%; <I>P</I>&nbsp;=&nbsp;.001).</p>
<p><b>Conclusions&nbsp;</b> Most evidence regarding surgical outcomes of sialorrhea management is low quality and heterogeneous. Despite this, most patients experience a subjective improvement following surgical treatment.</p>
]]></description>
<dc:creator><![CDATA[Reed, J., Mans, C. K., Brietzke, S. E.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:29 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Pediatric Otolaryngology, Salivary Gland Disorders, Pediatrics, Pediatrics, Other, Quality of Care, Evidence-Based Medicine, Surgery, Surgical Interventions, Surgical Interventions, Other, Prognosis/ Outcomes]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.110</dc:identifier>
<dc:title><![CDATA[Surgical Management of Drooling: A Meta-analysis [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>931</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>924</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/932?rss=1">
<title><![CDATA[Management of Nasolabial Cysts by Transnasal Endoscopic Marsupialization [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/932?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To evaluate hospitalization rates and duration of surgery associated with transnasal endoscopic marsupialization compared with sublabial excision in treating nasolabial cysts.</p>
<p><b>Design&nbsp;</b> Retrospective clinical series.</p>
<p><b>Setting&nbsp;</b> Large urban community hospital.</p>
<p><b>Patients&nbsp;</b> Consecutive sample of 57 patients with nasolabial cysts treated from January 1, 2000, to February 29, 2008.</p>
<p><b>Interventions&nbsp;</b> Sublabial excision in 23 patients (sublabial group) and transnasal endoscopic marsupialization in 34 patients (transnasal group). Among 57 patients, 47 underwent preoperative computed tomography.</p>
<p><b>Main Outcome Measures&nbsp;</b> History, clinical presentation, preoperative condition, histopathologic findings, treatment, complications, and outcomes.</p>
<p><b>Results&nbsp;</b> The mean duration of surgery was 91.3 minutes in the sublabial group and 29.5 minutes in the transnasal group (<I>P</I>&nbsp;=&nbsp;.003). The hospitalization rate was 100% (23 of 23) in the sublabial group and 59% (20 of 34) in the transnasal group (<I>P</I>&nbsp;&lt;&nbsp;.001). The medical costs were significantly lower in the transnasal group than in the sublabial group (<I>P</I>&nbsp;=&nbsp;.002). The follow-up period ranged from 6 to 85 months. Neither group of patients experienced any major complications or recurrences during the follow-up period.</p>
<p><b>Conclusion&nbsp;</b> Transnasal endoscopic marsupialization is an effective treatment for nasolabial cysts, is less costly, and has fewer complications than sublabial excision.</p>
]]></description>
<dc:creator><![CDATA[Chao, W.-C., Huang, C.-C., Chang, P.-H., Chen, Y.-L., Chen, C.-W., Lee, T.-J.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:29 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Endoscopy of Upper Aerodigestive Tract, General Rhinology, Surgery, Surgical Interventions, Endoscopy/ Minimally Invasive Surgery]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.111</dc:identifier>
<dc:title><![CDATA[Management of Nasolabial Cysts by Transnasal Endoscopic Marsupialization [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>935</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>932</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/936?rss=1">
<title><![CDATA[Effects of Synchronous Nasal Surgery on Posttonsillectomy Hemorrhage [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/936?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To evaluate the effects of synchronous nasal surgery on the rate of posttonsillectomy hemorrhage.</p>
<p><b>Design&nbsp;</b> Retrospective medical record review.</p>
<p><b>Setting&nbsp;</b> Military tertiary referral center.</p>
<p><b>Patients&nbsp;</b> Adult patients identified in our surgical database from June 1, 2000, through September 31, 2005, who had undergone tonsillectomy or uvulopalatopharyngoplasty with tonsillectomy (UPPPT) either alone or with synchronous nasal surgery.</p>
<p><b>Main Outcome Measures&nbsp;</b> The rate of posttonsillectomy hemorrhage was reviewed in all patients who underwent tonsillectomy or UPPPT at our medical center, and an investigation was conducted to determine whether synchronous nasal surgery altered this rate.</p>
<p><b>Results&nbsp;</b> A total of 1010 patients were included in this study, with a rate of posttonsillectomy hemorrhage of 5.5%. A total of 204 patients underwent synchronous nasal surgery. No significant difference was found between the hemorrhage rate in patients who underwent tonsillectomy or UPPPT alone and those who underwent synchronous nasal surgery (6.0% and 3.9%, respectively; <I>P</I>&nbsp;=&nbsp;.30). When these patients were further divided into those undergoing UPPPT and those undergoing synchronous nasal surgery, no significant difference in hemorrhage rate was found (6.2% and 2.0%, respectively; <I>P</I>&nbsp;=&nbsp;.06).</p>
<p><b>Conclusions&nbsp;</b> Synchronous nasal surgery does not appear to increase the rate of postoperative hemorrhage in patients who undergo tonsillectomy alone or in those who undergo UPPPT. This information may help persuade physicians to perform synchronous surgical procedures instead of staging surgical procedures. In this regard, the patient requires only 1 anesthetic and 1 postoperative course without the risk of increased postoperative hemorrhage.</p>
]]></description>
<dc:creator><![CDATA[Adams, M. T. A., Wilhelm, M. J., Demars, S. M., Harsha, W. J.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:29 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, General Rhinology, Otolaryngology/ Head & Neck Surgery, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.113</dc:identifier>
<dc:title><![CDATA[Effects of Synchronous Nasal Surgery on Posttonsillectomy Hemorrhage [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>939</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>936</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/940?rss=1">
<title><![CDATA[Radiology Quiz Case 1 [Clinical Problem Solving: Radiology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/940?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Bon-Mardion, N., Marcolla-Bouchetemble, A., Bouchetemble, P., Marie, J.-P., Dehesdin, D., Choussy, O.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:29 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Pediatric Otolaryngology, Radiology of Head & Neck, Pediatrics, Congenital Malformations, Diagnosis]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.133-a</dc:identifier>
<dc:title><![CDATA[Radiology Quiz Case 1 [Clinical Problem Solving: Radiology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>940</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>940</prism:startingPage>
<prism:section>Clinical Problem Solving: Radiology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/941?rss=1">
<title><![CDATA[Radiology Quiz Case 2 [Clinical Problem Solving: Radiology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/941?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Anand, T. S., Tatavarthy, S., Kumar, S.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:29 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Radiology of Head & Neck, Otolaryngology/ Head & Neck Surgery, Other, Radiologic Imaging, Diagnosis, Radiography]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.134-a</dc:identifier>
<dc:title><![CDATA[Radiology Quiz Case 2 [Clinical Problem Solving: Radiology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>941</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>941</prism:startingPage>
<prism:section>Clinical Problem Solving: Radiology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/942?rss=1">
<title><![CDATA[Radiology Quiz Case 1: Diagnosis [Clinical Problem Solving: Radiology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/942?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:29 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Pediatric Otolaryngology, Radiology of Head & Neck, Pediatrics, Congenital Malformations, Diagnosis]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.133-b</dc:identifier>
<dc:title><![CDATA[Radiology Quiz Case 1: Diagnosis [Clinical Problem Solving: Radiology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>943</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>942</prism:startingPage>
<prism:section>Clinical Problem Solving: Radiology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/943?rss=1">
<title><![CDATA[Radiology Quiz Case 2: Diagnosis [Clinical Problem Solving: Radiology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/943?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:29 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Radiology of Head & Neck, Otolaryngology/ Head & Neck Surgery, Other, Radiologic Imaging, Diagnosis, Radiography]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.134-b</dc:identifier>
<dc:title><![CDATA[Radiology Quiz Case 2: Diagnosis [Clinical Problem Solving: Radiology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>943</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>943</prism:startingPage>
<prism:section>Clinical Problem Solving: Radiology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/944?rss=1">
<title><![CDATA[Pathology Quiz Case 1 [Clinical Problem Solving: Pathology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/944?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Pitak-Arnnop, P., Chaine, A., Dhanuthai, K., Bertrand, J.-C., Bertolus, C.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:29 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Pathology of Head & Neck, Otolaryngology/ Head & Neck Surgery, Other, Diagnosis]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.101-a</dc:identifier>
<dc:title><![CDATA[Pathology Quiz Case 1 [Clinical Problem Solving: Pathology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>944</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>944</prism:startingPage>
<prism:section>Clinical Problem Solving: Pathology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/945?rss=1">
<title><![CDATA[Pathology Quiz Case 2 [Clinical Problem Solving: Pathology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/945?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Ganske, I., Faquin, W., Cunningham, M.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:29 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, General Rhinology, Pathology of Head & Neck, Diagnosis]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.102-a</dc:identifier>
<dc:title><![CDATA[Pathology Quiz Case 2 [Clinical Problem Solving: Pathology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>945</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>945</prism:startingPage>
<prism:section>Clinical Problem Solving: Pathology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/946?rss=1">
<title><![CDATA[Pathology Quiz Case 1: Diagnosis [Clinical Problem Solving: Pathology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/946?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:29 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Pathology of Head & Neck, Otolaryngology/ Head & Neck Surgery, Other, Diagnosis]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.101-b</dc:identifier>
<dc:title><![CDATA[Pathology Quiz Case 1: Diagnosis [Clinical Problem Solving: Pathology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>947</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>946</prism:startingPage>
<prism:section>Clinical Problem Solving: Pathology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/947?rss=1">
<title><![CDATA[Pathology Quiz Case 2: Diagnosis [Clinical Problem Solving: Pathology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/947?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:29 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, General Rhinology, Pathology of Head & Neck, Diagnosis]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.102-b</dc:identifier>
<dc:title><![CDATA[Pathology Quiz Case 2: Diagnosis [Clinical Problem Solving: Pathology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>948</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>947</prism:startingPage>
<prism:section>Clinical Problem Solving: Pathology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/949?rss=1">
<title><![CDATA[Primary Leiomyosarcoma of the Sphenoid Sinus [Clinical Note]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/949?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Ramakrishnan, V. R., Said, S., Kingdom, T. T.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:29 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Otolaryngology/ Head & Neck Surgery, General Rhinology, Neoplasms of Head & Neck, Paranasal Sinus Disease]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.114</dc:identifier>
<dc:title><![CDATA[Primary Leiomyosarcoma of the Sphenoid Sinus [Clinical Note]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>952</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>949</prism:startingPage>
<prism:section>Clinical Note</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/952?rss=1">
<title><![CDATA[Error in Author Affiliations in: Outcome of Tonsillectomy in Selected Patients With PFAPA Syndrome [Correction]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/952?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:29 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Pediatric Otolaryngology, Otolaryngology/ Head & Neck Surgery, Other, Pediatrics, Pediatrics, Other, Surgery, Surgical Interventions, Pediatric Surgery, Diagnosis]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.118</dc:identifier>
<dc:title><![CDATA[Error in Author Affiliations in: Outcome of Tonsillectomy in Selected Patients With PFAPA Syndrome [Correction]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>952</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>952</prism:startingPage>
<prism:section>Correction</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/9/953?rss=1">
<title><![CDATA[Aryepiglottic Abscess Manifesting as Epiglottitis [Clinical Note]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/9/953?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Reed, J., Shah, R. K., Jantausch, B., Choi, S. S.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 12:51:29 PDT</dc:date>
<dc:subject><![CDATA[Bacterial Infections, Otolaryngology/ Head & Neck Surgery, Pathology of Head & Neck, Otolaryngology/ Head & Neck Surgery, Other, Infectious Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.116</dc:identifier>
<dc:title><![CDATA[Aryepiglottic Abscess Manifesting as Epiglottitis [Clinical Note]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>955</prism:endingPage>
<prism:publicationDate>2009-09-01</prism:publicationDate>
<prism:startingPage>953</prism:startingPage>
<prism:section>Clinical Note</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/733?rss=1">
<title><![CDATA[Hiking along the Na Pali Coast of Kauai [About the Cover]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/733?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Otolaryngology/ Head & Neck Surgery, Other, Humanities]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.85</dc:identifier>
<dc:title><![CDATA[Hiking along the Na Pali Coast of Kauai [About the Cover]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>733</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>733</prism:startingPage>
<prism:section>About the Cover</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/734?rss=1">
<title><![CDATA[About This Journal [About This Journal]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/734?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:title><![CDATA[About This Journal [About This Journal]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>734</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>734</prism:startingPage>
<prism:section>About This Journal</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/738?rss=1">
<title><![CDATA[Prognostic Factors for Short-term Outcomes After Ossiculoplasty Using Multivariate Analysis With Logistic Regression [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/738?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To investigate prognostic factors for short-term hearing outcomes after ossiculoplasty.</p>
<p><b>Design&nbsp;</b> Retrospective study.</p>
<p><b>Setting&nbsp;</b> Tertiary referral and academic center.</p>
<p><b>Patients&nbsp;</b> Seven hundred twenty patients who underwent ossiculoplasty performed by a single surgeon from January 1, 1989, through December 31, 2006, and who were followed up for longer than 1 year.</p>
<p><b>Main Outcome Measures&nbsp;</b> Hearing outcomes were considered successful if the postoperative air-bone gap was 20 dB or less. The prognostic factors were analyzed using multivariate analysis with logistic regression.</p>
<p><b>Results&nbsp;</b> Hearing outcomes were successful in 505 patients (70.1%). Presence of the stapes superstructure, presence of the malleus handle, normal mucosa, normal stapes mobility, and use of local anesthesia were significantly favorable predictive factors.</p>
<p><b>Conclusions&nbsp;</b> Multivariate analysis should be performed to investigate prognostic factors of favorable short-term hearing outcomes after ossiculoplasty. Better knowledge of these predictive factors may contribute to the surgeon's judgment and the information given to patients.</p>
]]></description>
<dc:creator><![CDATA[Mishiro, Y., Sakagami, M., Adachi, O., Kakutani, C.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Audiology, Hearing Loss/ Deafness, Middle/ External Ear Disorders, Prognosis/ Outcomes]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.100</dc:identifier>
<dc:title><![CDATA[Prognostic Factors for Short-term Outcomes After Ossiculoplasty Using Multivariate Analysis With Logistic Regression [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>741</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>738</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/742?rss=1">
<title><![CDATA[Bone-Anchored Hearing Aid Implant Location in Relation to Skin Reactions [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/742?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To evaluate the effect of implant location and skin thickness on the frequency and degree of adverse skin reactions around the abutment.</p>
<p><b>Design&nbsp;</b> Retrospective multivariate analysis of implant position related to skin thickness and clinical variables.</p>
<p><b>Setting&nbsp;</b> Tertiary referral center.</p>
<p><b>Patients&nbsp;</b> Random sample of 248 patients with bone-anchored hearing aids.</p>
<p><b>Interventions&nbsp;</b> Bone-anchored hearing aid implant placement by means of the linear incision technique.</p>
<p><b>Mean Outcome Measures&nbsp;</b> Type and number of skin reactions and implant loss.</p>
<p><b>Results&nbsp;</b> The mean (SD) distance from the external auditory ear canal to implant was 48.8 (8.0) mm (range, 29-84 mm). The mean skin thickness was 5.5 (1.9) mm. Severe skin reactions (Holgers classification, 2-4) were seen in 46 of the 248 patients (18.5%). Implant loss occurred in 4 patients (1.6%). Three implants were lost owing to failed osseointegration (1.3%), and another implant was removed because of deterioration of cochlear function (0.9%). No implant was lost as a result of infection.</p>
<p><b>Conclusion&nbsp;</b> Implant location and skin thickness were not correlated with implant loss or the frequency or degree of adverse skin reactions around the abutment.</p>
]]></description>
<dc:creator><![CDATA[Faber, H. T., de Wolf, M. J. F., de Rooy, J. W. J., Hol, M. K. S., Cremers, C. W. R. J., Mylanus, E. A. M.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:subject><![CDATA[Dermatology, Otolaryngology/ Head & Neck Surgery, Cochlear Implantation, Dermatologic Disorders, Dermatologic Disorders, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.99</dc:identifier>
<dc:title><![CDATA[Bone-Anchored Hearing Aid Implant Location in Relation to Skin Reactions [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>747</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>742</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/748?rss=1">
<title><![CDATA[Otorrhea in Infants With Tympanostomy Tubes Before and After Surgical Repair of a Cleft Palate [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/748?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To compare the incidence of otorrhea in a group of infants with cleft palate (CP) and tympanostomy tubes before and after surgical repair of the CP.</p>
<p><b>Design&nbsp;</b> Prospective observational study.</p>
<p><b>Setting&nbsp;</b> Otolaryngology clinic at a tertiary care children's hospital.</p>
<p><b>Patients&nbsp;</b> Thirty-three infants with CP and middle ear effusions who underwent tympanostomy tube placement. Subjects were observed from the time of tube placement until 6 months after CP repair.</p>
<p><b>Main Outcome Measure&nbsp;</b> Incidence of otorrhea before and after CP repair.</p>
<p><b>Results&nbsp;</b> Subjects were observed a mean of 6.3 months before CP repair and 6 months after CP repair. Before CP repair, 11 of 33 infants (33%) had no episodes of otorrhea, compared with 22 of 33 (67%) after CP repair (<I>P</I>&nbsp;=&nbsp;.007). Fourteen infants (43%) had 2 or more episodes of otorrhea before CP repair compared with 2 (6%) after CP repair (<I>P</I>&nbsp;=&nbsp;.001). Before CP repair, significantly fewer tubes were patent at the time of the audiologic evaluation compared with after CP repair (39 of 62 [63%] vs 52 of 66 [79%]; <I>P</I>&nbsp;=&nbsp;.048). Average speech reception threshold for the infants with tympanostomy tubes before CP repair was 18.1 dB compared with 12.6 dB after CP repair (<I>P</I>&nbsp;=&nbsp;.01).</p>
<p><b>Conclusion&nbsp;</b> The incidence of otorrhea after tympanostomy tube placement before CP repair is higher than the incidence after CP repair, although more than half of all infants (19 [58%]) had either 1 or no episodes of otorrhea before CP repair.</p>
]]></description>
<dc:creator><![CDATA[Curtin, G., Messner, A. H., Chang, K. W.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Audiology, Congenital Anomalies of Head & Neck, Hearing Loss/ Deafness, Middle/ External Ear Disorders, Pediatric Otolaryngology, Pediatrics, Congenital Malformations, Neonatology and Infant Care]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.106</dc:identifier>
<dc:title><![CDATA[Otorrhea in Infants With Tympanostomy Tubes Before and After Surgical Repair of a Cleft Palate [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>751</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>748</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/752?rss=1">
<title><![CDATA[Radiofrequency, High-Frequency, and Electrocautery Treatments vs Partial Inferior Turbinotomy: Microscopic and Macroscopic Effects on Nasal Mucosa [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/752?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To compare the microscopic and macroscopic effects of radiofrequency, high-frequency, and electrocautery therapies with partial inferior turbinotomy in the treatment of nasal obstruction caused by inferior turbinate hypertrophy.</p>
<p><b>Design&nbsp;</b> Nonrandomized controlled trial.</p>
<p><b>Setting&nbsp;</b> Department of Otolaryngology&ndash;Head and Neck Surgery, University of Genoa.</p>
<p><b>Patients&nbsp;</b> The study included 80 patients affected by nasal obstruction from hypertrophied inferior turbinates.</p>
<p><b>Interventions&nbsp;</b> Homogeneous patient groups A, B, C, and D underwent radiofrequency, high-frequency, and electrocautery treatments and partial inferior turbinotomy, respectively, to surgically reduce hypertrophied inferior turbinates.</p>
<p><b>Main Outcomes Measures&nbsp;</b> Prior to surgery and at 7-day and 2-month follow-up evaluations, patients' outcomes were assessed via visual analogue scale, nasal endoscopy, nasal monofilament test, nasal mucociliary transport time (NMTT), anterior active rhinomanometry, and histologic examination of microbiopsy specimens from the inferior turbinate mucosa.</p>
<p><b>Results&nbsp;</b> Compared with groups A, B, and C 2 months after surgery, group D showed a lower subjective assessment of symptoms score, normal NMTT (vs an increase in all other groups), lower stimulus to trigger a touch response at monofilament test (vs hyposensitivity in the other groups), and absence of histologic changes.</p>
<p><b>Conclusions&nbsp;</b> To our knowledge, no one has previously performed comparative studies to conclusively demonstrate which surgical technique is ideal. Our results show that the partial inferior nasal turbinotomy is the best method of treatment because it most effectively maintains satisfactory nasal physiologic integrity without damaging nasal mucosa or underlying nerves.</p>
]]></description>
<dc:creator><![CDATA[Salzano, F.-A., Mora, R., Dellepiane, M., Zannis, I., Salzano, G., Moran, E., Salami, A.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, General Rhinology]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.87</dc:identifier>
<dc:title><![CDATA[Radiofrequency, High-Frequency, and Electrocautery Treatments vs Partial Inferior Turbinotomy: Microscopic and Macroscopic Effects on Nasal Mucosa [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>758</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>752</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/759?rss=1">
<title><![CDATA[Combination of Autologous Fascia Lata and Fat Injection Into the Vocal Fold via the Cricothyroid Gap for Unilateral Vocal Fold Paralysis [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/759?rss=1</link>
<description><![CDATA[
<p><b>Objectives&nbsp;</b> To apply the technique of injection of a combination of autologous fascia lata and fat into the vocal fold via the cricothyroid gap for unilateral vocal fold paralysis and to evaluate the therapeutic effect in 12 patients who underwent the procedure.</p>
<p><b>Design&nbsp;</b> Retrospective analysis of 12 patients.</p>
<p><b>Setting&nbsp;</b> Academic research.</p>
<p><b>Patients&nbsp;</b> A mixture of autologous fascia lata and fat was injected into the thyroarytenoid muscle of the paralyzed vocal fold in 12 patients.</p>
<p><b>Main Outcome Measures&nbsp;</b> Videolaryngostroboscopy was performed to observe the changes to the vocal fold. The patients' phonatory function before and after surgery was assessed by computerized acoustic analysis and by blinded perceptual evaluation.</p>
<p><b>Results&nbsp;</b> Videolaryngostroboscopy demonstrated that the paralyzed vocal folds in these patients were pushed medially after the procedure. Statistically significant improvements were found in the perturbation measurements (jitter and shimmer), harmonics to noise ratio, and maximum phonation time. Ratings by a panel of voice experts also showed each voice to be statistically significantly improved after the procedure. No complications were noted.</p>
<p><b>Conclusion&nbsp;</b> A combination of autologous fascia lata and fat injected into the vocal fold for unilateral vocal fold paralysis is a safe and effective therapy.</p>
]]></description>
<dc:creator><![CDATA[Cheng, Y., Li, Z.-q., Huang, J.-z., Xue, F., Jiang, M.-j., Wu, K.-m., Wang, Q.-p.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Voice Disorders]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.91</dc:identifier>
<dc:title><![CDATA[Combination of Autologous Fascia Lata and Fat Injection Into the Vocal Fold via the Cricothyroid Gap for Unilateral Vocal Fold Paralysis [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>763</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>759</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/764?rss=1">
<title><![CDATA[Intranasal Localization of the Lacrimal Sac [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/764?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To optimize the approach to the lacrimal sac during intranasal dacryocystorhinostomy.</p>
<p><b>Design&nbsp;</b> Microscopic measurement of anatomical landmarks in cadaver sagittal head sections.</p>
<p><b>Setting&nbsp;</b> The anatomy department of a large university hospital.</p>
<p><b>Participants&nbsp;</b> Twenty adult cadaver sagittal head sections (12 right and 8 left) fixed with 10% formaldehyde solution were evaluated.</p>
<p><b>Intervention&nbsp;</b> During endoscopic dissections, the maxillary line, lacrimomaxillary suture, nasolacrimal duct, and lacrimal sac were exposed.</p>
<p><b>Main Outcome Measures&nbsp;</b> Greater knowledge of the relationship among anatomical structures.</p>
<p><b>Results&nbsp;</b> The entire lacrimal sac was in 2 of 20 sides anterior and in 3 of 20 sides posterior to the axilla of the middle nasal concha. The fornix of the lacrimal sac was situated above the axilla in all sides. We evaluated the localization of the lacrimal sac to the maxillary line, which is of clinical importance in intranasal osteotomy during dacryocystorhinostomy. In 17 of 20 sides it is possible to reveal the axilla of the middle nasal concha during osteotomy.</p>
<p><b>Conclusions&nbsp;</b> Underexposure or lack of true localization of the sac are the most frequently encountered reasons for dacryocystorhinostomy failure. The maxillary line and adhesion point of the middle nasal concha are the 2 most important landmarks in localization of the sac. A mucosal incision anterior to the maxillary line and dissection up to the point where the middle concha adheres, followed by osteotomy on the lacrimomaxillary suture, nearly always ensure the exposure of the sac.</p>
]]></description>
<dc:creator><![CDATA[Orhan, M., Saylam, C. Y., Midilli, R.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:subject><![CDATA[Ophthalmology, Ophthalmological Procedures, Ophthalmological Procedures, Other, Otolaryngology/ Head & Neck Surgery, Otolaryngology/ Head & Neck Surgery, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.94</dc:identifier>
<dc:title><![CDATA[Intranasal Localization of the Lacrimal Sac [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>770</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>764</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/771?rss=1">
<title><![CDATA[Upregulation of Elafin and Cystatin C in the Ethmoid Sinus Mucosa of Patients With Chronic Sinusitis [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/771?rss=1</link>
<description><![CDATA[
<p><b>Objectives&nbsp;</b> To investigate the expression levels and distribution patterns of elafin and cystatin C in normal and inflammatory human sinus mucosa and to evaluate their roles in chronic sinusitis.</p>
<p><b>Design&nbsp;</b> A controlled, prospective study.</p>
<p><b>Setting&nbsp;</b> A tertiary academic institution.</p>
<p><b>Patients&nbsp;</b> Normal sinus mucosa was obtained from the ethmoid sinus during surgery in 30 patients with blowout fractures. Inflammatory sinus mucosa was obtained from 30 patients undergoing endoscopic sinus surgery for chronic polypoid sinusitis.</p>
<p><b>Interventions&nbsp;</b> Reverse transcription&ndash;polymerase chain reaction, immunohistochemical analysis, and Western blotting.</p>
<p><b>Main Outcome Measures&nbsp;</b> Expression levels and distribution patterns of elafin and cystatin C in normal and inflammatory mucosa.</p>
<p><b>Results&nbsp;</b> Expression of elafin and cystatin C messenger RNAs and proteins analyzed by means of reverse transcription&ndash;polymerase chain reaction and Western blot was detected in all normal and inflammatory sinus mucosa tested. Their expression levels were increased in inflammatory vs normal mucosa. Elafin in normal and inflammatory sinus mucosa was distinctly expressed in goblet cells, which are increased in inflammatory sinus mucosa. Elafin in submucosal glands was usually weak in staining intensity, except for a few scattered submucosal glands showing moderate intensity in inflammatory sinus mucosa. Cystatin C was also localized in goblet cells and submucosal glands in normal and inflammatory mucosa. Staining intensity was increased more in inflammatory vs normal sinus mucosa.</p>
<p><b>Conclusion&nbsp;</b> Elafin and cystatin C may play an important role in the protection of normal sinus mucosa and further in regulation of the inflammatory condition in chronic sinusitis.</p>
]]></description>
<dc:creator><![CDATA[Lee, C. W., Kim, T. H., Lee, H. M., Lee, S. H., Lee, S. H., Yoo, J. H., Kim, Y. S., Lee, S. H.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, General Rhinology, Paranasal Sinus Disease]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.97</dc:identifier>
<dc:title><![CDATA[Upregulation of Elafin and Cystatin C in the Ethmoid Sinus Mucosa of Patients With Chronic Sinusitis [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>775</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>771</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/776?rss=1">
<title><![CDATA[Percutaneous Corticosteroid Injection for Vocal Fold Polyp [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/776?rss=1</link>
<description><![CDATA[
<p><b>Objectives&nbsp;</b> To evaluate the applicability and effectiveness of percutaneous corticosteroid injection in patients with vocal fold polyp and to describe its advantages and limitations in this group of patients.</p>
<p><b>Design&nbsp;</b> Prospective case series.</p>
<p><b>Setting&nbsp;</b> Tertiary care teaching hospital.</p>
<p><b>Patients&nbsp;</b> Twenty-four patients with vocal fold polyp treated between March 1 and December 31, 2007.</p>
<p><b>Interventions&nbsp;</b> Percutaneous corticosteroid injection performed with the patient under topical anesthesia. Stroboscopic examination was carried out to evaluate the postoperative response.</p>
<p><b>Main Outcome Measures&nbsp;</b> The Grade of the Severity of Dysphonia, Roughness, Breathiness, Asthenicity, and Strain (GRBAS) scale and the Voice Handicap Index were used for subjective assessments. Phonatory results including maximum phonation time, mean flow rate, jitter, shimmer, and noise to harmonic ratio were also collected for objective evaluations.</p>
<p><b>Results&nbsp;</b> The surgery was completed smoothly in 22 of the 24 patients, typically within 20 minutes. No complications were noted. The overall response rate by stroboscopy was 91% (20 of 22 patients) and complete remission rate was 59% (13 of 22). A significant improvement was noted between preoperative and postoperative results on the GRBAS scale (<I>P</I>&nbsp;&lt;&nbsp;.001, <I>P</I>&nbsp;&lt;&nbsp;.001, <I>P</I>&nbsp;=&nbsp;.003, <I>P</I>&nbsp;=&nbsp;.001, and <I>P</I>&nbsp;=&nbsp;.002, respectively, for the 5 measures). Mean Voice Handicap Index (<I>P</I>&nbsp;=&nbsp;.001), maximum phonation time (<I>P</I>&nbsp;=&nbsp;.02), jitter (<I>P</I>&nbsp;=&nbsp;.006), shimmer (<I>P</I>&nbsp;=&nbsp;.001), and noise to harmonic ratio (<I>P</I>&nbsp;=&nbsp;.01) also improved significantly after percutaneous corticosteroid injection.</p>
<p><b>Conclusions&nbsp;</b> Percutaneous corticosteroid injection can be used to manage vocal fold polyps with low invasiveness and minimal morbidity. It offers a simple and cost-effective alternative to traditional direct microlaryngoscopic procedures.</p>
]]></description>
<dc:creator><![CDATA[Hsu, Y.-B., Lan, M.-C., Chang, S.-Y.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Laryngology/ Speech/ Language Pathology, Voice Disorders, Drug Therapy, Drug Therapy, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.86</dc:identifier>
<dc:title><![CDATA[Percutaneous Corticosteroid Injection for Vocal Fold Polyp [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>780</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>776</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/781?rss=1">
<title><![CDATA[Transnasal Balloon Dilation of the Esophagus [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/781?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To describe the safety of transnasal balloon dilation of the esophagus.</p>
<p><b>Design&nbsp;</b> Retrospective case series.</p>
<p><b>Setting&nbsp;</b> Two tertiary care institutions.</p>
<p><b>Patients&nbsp;</b> All patients undergoing transnasal balloon dilation of the esophagus.</p>
<p><b>Main Outcome Measure&nbsp;</b> Complications.</p>
<p><b>Results&nbsp;</b> Fifty-four transnasal esophageal balloon dilations were performed in 38 patients. The mean age of the cohort was 65 years (range, 13-88 years). Twenty-nine patients were male (76%). Twenty procedures were performed using only topical anesthesia in the office setting. Seven patients (18%) were postlaryngectomy, and 15 patients (39%) had a history of head and neck radiation therapy. The upper esophageal sphincter (UES) was the most frequent dilation site (63%), followed by proximal/mid esophagus (26%), lower esophageal sphincter (LES) (7.4%), and both the UES and LES (3.7%). Indications included cricopharyngeal dysfunction, benign stricture, web, and Schatzki ring. Two procedures (3.7%) were aborted secondary to self-limited laryngospasm or gagging. There were no clinically significant complications.</p>
<p><b>Conclusions&nbsp;</b> Transnasal esophageal balloon dilation can be performed in unsedated or sedated patients with a very low complication rate. The procedure is well tolerated in 96% of patients. This technique, formerly available only through larger caliber oral gastroscopes and under sedation, allows for office-based esophageal balloon dilation in an otolaryngology practice.</p>
]]></description>
<dc:creator><![CDATA[Rees, C. J., Fordham, T., Belafsky, P. C.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Endoscopy of Upper Aerodigestive Tract, Surgery, Surgical Interventions, Endoscopy/ Minimally Invasive Surgery]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.115</dc:identifier>
<dc:title><![CDATA[Transnasal Balloon Dilation of the Esophagus [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>783</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>781</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/784?rss=1">
<title><![CDATA[Photodynamic Therapy for Head and Neck Dysplasia and Cancer [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/784?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To determine the response of dysplasia, carcinoma in situ (CIS), and T1 carcinoma of the oral cavity and larynx to photodynamic therapy with porfimer sodium.</p>
<p><b>Design&nbsp;</b> Prospective trial.</p>
<p><b>Setting&nbsp;</b> A National Cancer Institute&ndash;designated cancer institute.</p>
<p><b>Patients&nbsp;</b> Patients with primary or recurrent moderate to severe oral or laryngeal dysplasia, CIS, or T1N0 carcinoma.</p>
<p><b>Intervention&nbsp;</b> Porfimer sodium, 2 mg/kg of body weight, was injected intravenously 48 hours before treatment. Light at 630 nm for photosensitizer activation was delivered from an argon laser or diode laser using lens or cylindrical diffuser fibers. The light dose was 50 J/cm<sup>2</sup> for dysplasia and CIS and 75 J/cm<sup>2</sup> for carcinoma.</p>
<p><b>Main Outcome Measures&nbsp;</b> Response was evaluated at 1 week and at 1 month and then at 3-month intervals thereafter. Response options were complete (CR), partial (PR), and no (NR) response. Posttreatment biopsies were performed in all patients with persistent and recurrent visible lesions.</p>
<p><b>Results&nbsp;</b> Thirty patients were enrolled, and 26 were evaluable. Mean follow-up was 15 months (range, 7-52 months). Twenty-four patients had a CR, 1 had a PR, and 1 had NR. Three patients with oral dysplasia with an initial CR experienced recurrence in the treatment field. All the patients with NR, a PR, or recurrence after an initial CR underwent salvage treatment. Temporary morbidities included edema, pain, hoarseness, and skin phototoxicity.</p>
<p><b>Conclusion&nbsp;</b> Photodynamic therapy with porfimer sodium is an effective treatment alternative, with no permanent sequelae, for oral and laryngeal dysplasia and early carcinoma.</p>
<p><b>Trial Registration&nbsp;</b> clinicaltrials.gov Identifier: <inter-ref locator-type="url" locator="http://clinicaltrials.gov/show/NCT00530088">NCT00530088</inter-ref></p>
]]></description>
<dc:creator><![CDATA[Rigual, N. R., Thankappan, K., Cooper, M., Sullivan, M. A., Dougherty, T., Popat, S. R., Loree, T. R., Biel, M. A., Henderson, B.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Dentistry/ Oral Medicine, Otolaryngology/ Head & Neck Surgery, Laryngology/ Speech/ Language Pathology, Neoplasms of Head & Neck]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.98</dc:identifier>
<dc:title><![CDATA[Photodynamic Therapy for Head and Neck Dysplasia and Cancer [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>788</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>784</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/789?rss=1">
<title><![CDATA[The Role of Pain in Head and Neck Cancer Recurrence and Survivorship [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/789?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To examine pain, a common symptom in patients with head and neck cancer, and its relationship to recurrence and survivorship.</p>
<p><b>Design&nbsp;</b> Prospective, observational study.</p>
<p><b>Setting&nbsp;</b> Tertiary care institution.</p>
<p><b>Patients&nbsp;</b> A total of 339 patients with head and neck carcinomas who participated in the Department of Otolaryngology's Outcomes Assessment Project between February 28, 1998, and November 30, 2001. Of 355 patients enrolled during this period, 7 were omitted from the study because they presented with persistent disease and 9 were omitted owing to a lack of valid pain data. Data on health-related quality of life were collected from the remaining patients at diagnosis and then at 3, 6, 9, and 12 months after diagnosis.</p>
<p><b>Intervention&nbsp;</b> Administration of surveys and questionnaires.</p>
<p><b>Main Outcome Measures&nbsp;</b> The relationship of self-reported pain level with health-related quality of life during the first year, recurrence status, and 5-year disease-specific survivorship was determined through univariate and multivariate analyses.</p>
<p><b>Results&nbsp;</b> Pain was associated with age, general physical and mental health conditions, depressive symptoms, survival rate, and recurrence within the first year. The 5-year survival rate was 81.8% for patients with low posttreatment pain and 65.1% for those with high pain. Posttreatment pain and tumor site were independent predictors of recurrence. Pain level, age, and treatment modality were independent predictors of 5-year survival.</p>
<p><b>Conclusion&nbsp;</b> Because of its association with recurrence and survival, pain within the first year of treatment for head and neck cancer is an important symptom that should be appropriately monitored and managed during routine follow-up.</p>
]]></description>
<dc:creator><![CDATA[Scharpf, J., Karnell, L. H., Christensen, A. J., Funk, G. F.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Oncology, Other, Otolaryngology/ Head & Neck Surgery, Neoplasms of Head & Neck, Pain, Quality of Life, Prognosis/ Outcomes]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.107</dc:identifier>
<dc:title><![CDATA[The Role of Pain in Head and Neck Cancer Recurrence and Survivorship [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>794</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>789</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/795?rss=1">
<title><![CDATA[Regional Control of Melanoma Neck Node Metastasis After Selective Neck Dissection With or Without Adjuvant Radiotherapy [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/795?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To examine the effect of adjuvant radiotherapy on regional control of melanoma neck node metastasis.</p>
<p><b>Design&nbsp;</b> A single-institution retrospective study.</p>
<p><b>Setting&nbsp;</b> Tertiary care cancer center.</p>
<p><b>Patients&nbsp;</b> The study included 64 patients with melanoma neck node metastasis who were treated with neck dissection between 1989 and 2004 in The Netherlands Cancer Institute, Amsterdam. Twenty-four patients were treated with surgery only (15 modified radical neck dissections [MRNDs] and 9 selective neck dissections [SNDs]) (S group), and 40 patients underwent surgery (28 MRNDs and 12 SNDs) and adjuvant radiotherapy (S+RT group).</p>
<p><b>Results&nbsp;</b> Prognostic factors, ie, number of nodes, size of nodes, and extracapsular extension, were worse in the S+RT group. With a median follow-up of 2.5 years, the 2-year ipsilateral regional recurrence (RR) rate was 18% in the S+RT group and 46% in the S group. This 28% difference in RR was not statistically significant (<I>P</I>&nbsp;=&nbsp;.16). However, evaluation of the effect of adjuvant RT in multivariate analysis revealed a significant reduction of the RR rate after correction for the number of involved nodes (<I>P</I>&nbsp;=&nbsp;.04). In the S group, SND was associated with a trend toward worse RR rate compared with MRND but was not statistically significant in univariate analysis (<I>P</I>&nbsp;=&nbsp;.08). The type of neck dissection did not influence the RR rate in the S+RT group (<I>P</I>&nbsp;=&nbsp;.60). Three of the 4 RRs occurred outside the dissected volume after SND in the S group.</p>
<p><b>Conclusions&nbsp;</b> Based on our findings, we conclude that, compared with extended neck dissection, SND leads to inferior regional control in patients with melanoma neck node metastasis who are not treated with RT, even those with low-risk neck disease. Furthermore, our results suggest that adjuvant RT improves regional control in patients with 2 or more involved nodes.</p>
]]></description>
<dc:creator><![CDATA[Hamming-Vrieze, O., Balm, A. J. M., Heemsbergen, W. D., Hooft van Huysduynen, T., Rasch, C. R. N.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Skin Cancer, Oncology, Other, Dermatology, Otolaryngology/ Head & Neck Surgery, Dermatologic Disorders, Neoplasms of Head & Neck, Melanoma]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.80</dc:identifier>
<dc:title><![CDATA[Regional Control of Melanoma Neck Node Metastasis After Selective Neck Dissection With or Without Adjuvant Radiotherapy [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>800</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>795</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/801?rss=1">
<title><![CDATA[Microvascular Flap Reconstruction of Major Pharyngeal Resections With the Intent of Laryngeal Preservation [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/801?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To determine the functional outcome in patients undergoing pharyngeal reconstruction with free tissue transfer with the intent of functional laryngeal preservation.</p>
<p><b>Design&nbsp;</b> Retrospective medical record review.</p>
<p><b>Setting&nbsp;</b> Academic tertiary care hospital.</p>
<p><b>Patients&nbsp;</b> The study population comprised 45 patients who underwent a major pharyngeal resection with or without a partial laryngeal resection (2 patients died perioperatively, leaving 43 to evaluate). The majority (n&nbsp;=&nbsp;35 [81%]) had advanced (T3 or T4) primary tumors at presentation and underwent subsequent reconstruction using free tissue transfer at a tertiary care hospital.</p>
<p><b>Main Outcome Measures&nbsp;</b> The rate of functional larynx preservation, best swallow score based on the Functional Outcome Swallowing Scale, and need for tracheostomy. Thirteen independent variables relevant to function and 6 postoperative outcome variables were studied following treatment, and their correlation with laryngeal function was determined.</p>
<p><b>Results&nbsp;</b> Of the 43 patients, 35 (81%) had T3 (n&nbsp;=&nbsp;9) or T4 (n&nbsp;=&nbsp;26) squamous cell carcinoma at presentation. There was 100% flap survival. Thirty-one patients (72%) tolerated an oral diet, with 24 (56%) achieving an exclusively oral diet. Only a history of gastroesophageal reflux disease had a statistically significant correlation with poor swallowing; having had a cranial nerve removed did not achieve statistical significance (<I>P</I>&nbsp;=&nbsp;.06). The majority of patients had their best swallow by 10 months. Of the 43 patients, 42 (97%) achieved native laryngeal speech and 36 (84%) were decannulated. The need for a tracheostomy did not correlate with any of the preoperative independent variables.</p>
<p><b>Conclusions&nbsp;</b> Free tissue transfer allows for successful reconstruction of complex pharyngeal defects that functionally threaten the remaining larynx. In properly selected patients, functional laryngeal preservation, decannulation, and use of laryngeal speech can be reliably achieved. Excellent swallowing function can less reliably be predicted.</p>
]]></description>
<dc:creator><![CDATA[Sumer, B. D., Gastman, B. R., Nussenbaum, B., Gao, F., Haughey, B. H.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Cancer Reconstruction of Head & Neck, Laryngology/ Speech/ Language Pathology, Neoplasms of Head & Neck, Surgery, Surgical Interventions, Surgical Oncology]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.84</dc:identifier>
<dc:title><![CDATA[Microvascular Flap Reconstruction of Major Pharyngeal Resections With the Intent of Laryngeal Preservation [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>806</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>801</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/807?rss=1">
<title><![CDATA[Plasma Osteopontin Levels in Patients With Head and Neck Cancer Undergoing Chemoradiotherapy [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/807?rss=1</link>
<description><![CDATA[
<p><b>Objectives&nbsp;</b> To explore the prognostic role of plasma levels of osteopontin (OPN), a phosphoglycoprotein with adhesive properties, in patients with head and neck squamous cell carcinoma (HNSCC) undergoing concomitant chemoradiotherapy. Previous studies have proposed OPN level as a prognostic factor in several cancers.</p>
<p><b>Design&nbsp;</b> Prospective analysis of plasma OPN levels, before and within 12 weeks after treatment, in a cohort of patients with HNSCC undergoing platinum-based chemoradiotherapy at our center.</p>
<p><b>Setting&nbsp;</b> Academic center.</p>
<p><b>Patients&nbsp;</b> Sixty-nine patients diagnosed as having HNSCC.</p>
<p><b>Interventions&nbsp;</b> Plasma levels of OPN were assessed before the start and after the conclusion of chemoradiotherapy by using an enzyme-linked immunosorbency assay kit. Chemoradiotherapy was exclusive (n&nbsp;=&nbsp;52) or adjuvant to surgery (n&nbsp;=&nbsp;17).</p>
<p><b>Main Outcome Measures&nbsp;</b> Levels of OPN were correlated with clinicopathological characteristics, response to treatment, and overall survival.</p>
<p><b>Results&nbsp;</b> Pretreatment plasma OPN levels were higher in patients with advanced T and N stages compared with patients with early stages (<I>P</I>&nbsp;=&nbsp;.009 and .07, respectively). Mean (SD) plasma levels of OPN measured before (102.5 [68.1] ng/mL) and after (104.0 [53.6] ng/mL) treatment did not differ (<I>P</I>&nbsp;=&nbsp;.18, paired <I>t</I> test). Pretreatment and posttreatment levels of OPN were lower in patients who achieved a complete response compared with those who failed to respond (75.0 [41.5] vs 131.2 [82.9] ng/mL [<I>P</I>&nbsp;=&nbsp;.005] and 86.8 [40.5] vs 141.6 [58.4] ng/mL [<I>P</I>&nbsp;=&nbsp;.004], respectively). Patients with high pretreatment OPN levels (>82.1 ng/mL) had shorter survival time (<I>P</I>&nbsp;&lt;&nbsp;.001). Posttreatment OPN levels were marginally (<I>P</I>&nbsp;=&nbsp;.10) associated with survival time in univariate analysis.</p>
<p><b>Conclusions&nbsp;</b> In patients with HNSCC undergoing chemoradiotherapy, a low pretreatment plasma OPN level is associated with treatment response and better survival. Modulation of OPN levels by chemoradiotherapy may also be associated with outcome. Further studies with serial measurement of OPN levels are warranted in these patients.</p>
]]></description>
<dc:creator><![CDATA[Snitcovsky, I., Leitao, G. M., Pasini, F. S., Brunialti, K. C. S., Mangone, F. R. R., Maistro, S., de Castro, G., Villar, R. C., Federico, M. H. H.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Oncology, Other, Otolaryngology/ Head & Neck Surgery, Neoplasms of Head & Neck, Radiation Therapy, Prognosis/ Outcomes, Drug Therapy, Drug Therapy, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.103</dc:identifier>
<dc:title><![CDATA[Plasma Osteopontin Levels in Patients With Head and Neck Cancer Undergoing Chemoradiotherapy [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>811</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>807</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/812?rss=1">
<title><![CDATA[Ratio of Metalloproteinase 2 to Tissue Inhibitor of Metalloproteinase 2 in Medullary Thyroid Carcinoma [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/812?rss=1</link>
<description><![CDATA[
<p><b>Objectives&nbsp;</b> To develop an index for the ratio of metalloproteinase 2 (MMP-2) to its tissue inhibitor (TIMP-2) in immunostained medullary thyroid carcinoma specimens and to correlate it with clinical and pathologic prognostic factors. Metalloproteinases, enzymes related to the degradation of the extracellular matrix, take part in carcinogenesis and have been associated with the prognosis of neoplasias. Nevertheless, medullary carcinoma is rarely considered in research analysis. Researchers tend to favor the ratio of enzymes to their inhibitors over the absolute concentrations of these enzymes.</p>
<p><b>Design&nbsp;</b> Retrospective study of surgical samples.</p>
<p><b>Setting&nbsp;</b> Head and Neck Surgery and Endocrinology Departments, Universidade de S&atilde;o Paulo Medical School Hospital.</p>
<p><b>Patients&nbsp;</b> Surgical specimens from 33 patients who had been observed for a mean of 76.8 months (range, 4-201 months) were immunohistochemically stained for MMP-2 and TIMP-2. Only patients whose clinical and pathologic data were complete and whose specimens were preserved were included in the study.</p>
<p><b>Main Outcome Measures&nbsp;</b> The ratio between the expressions of MMP-2 and TIMP-2 was based on a staining index (immunostaining extent and intensity) of each of the markers.</p>
<p><b>Results&nbsp;</b> Proportionally large expressions of TIMP-2 over MMP-2 correlated with low occurrences of positive findings on initial cervical examination for the presence of thyroid nodules and/or lymphadenopathy (<I>P</I>&nbsp;=&nbsp;.02) and cervical lymph node metastases (<I>P</I>&nbsp;&lt;&nbsp;.001), conditions correlated with prognosis. A correlation with cure at the end of follow-up (<I>P</I>&nbsp;=&nbsp;.01) was also observed. (<I>P</I>&lt;&nbsp;.05 was considered statistically significant.)</p>
<p><b>Conclusion&nbsp;</b> The ratio of MMP-2 to TIMP-2 expression is an additional and novel prognostic predictor of the outcome of medullary carcinoma treated surgically.</p>
]]></description>
<dc:creator><![CDATA[Cavalheiro, B. G., Junqueira, C. R., Brandao, L. G.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Otolaryngology/ Head & Neck Surgery, Endocrine Disease of Head & Neck, Neoplasms of Head & Neck, Prognosis/ Outcomes, Endocrine Diseases, Thyroid/ Parathyroid Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.92</dc:identifier>
<dc:title><![CDATA[Ratio of Metalloproteinase 2 to Tissue Inhibitor of Metalloproteinase 2 in Medullary Thyroid Carcinoma [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>817</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>812</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/818?rss=1">
<title><![CDATA[Ecthyma Gangrenosum: An Unusual Cutaneous Manifestation of the Head and Neck [Clinical Note]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/818?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Funk, E., Ivan, D., Gillenwater, A. M.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:subject><![CDATA[Bacterial Infections, Dermatology, Otolaryngology/ Head & Neck Surgery, Dermatologic Disorders, Otolaryngology/ Head & Neck Surgery, Other, Diagnosis, Dermatologic Disorders, Other, Hematology/ Hematologic Malignancies, Hematology, Other, Infectious Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.93</dc:identifier>
<dc:title><![CDATA[Ecthyma Gangrenosum: An Unusual Cutaneous Manifestation of the Head and Neck [Clinical Note]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>820</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>818</prism:startingPage>
<prism:section>Clinical Note</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/821?rss=1">
<title><![CDATA[Major Tracheal Tear and Bilateral Tension Pneumothorax Complicating Percutaneous Tracheostomy [Clinical Note]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/821?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Stupnik, T., Steblaj, S., Sok, M.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Otolaryngology/ Head & Neck Surgery, Other, Surgery, Surgical Interventions, Thoracic Surgery]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.88</dc:identifier>
<dc:title><![CDATA[Major Tracheal Tear and Bilateral Tension Pneumothorax Complicating Percutaneous Tracheostomy [Clinical Note]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>823</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>821</prism:startingPage>
<prism:section>Clinical Note</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/824?rss=1">
<title><![CDATA[Kaposiform Hemangioendothelioma of the Tongue in an Adult [Clinical Note]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/824?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[White, J. B., Pullman, J., Wenig, B., Smith, R. V.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Otolaryngology/ Head & Neck Surgery, Neoplasms of Head & Neck]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.104</dc:identifier>
<dc:title><![CDATA[Kaposiform Hemangioendothelioma of the Tongue in an Adult [Clinical Note]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>826</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>824</prism:startingPage>
<prism:section>Clinical Note</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/828?rss=1">
<title><![CDATA[Radiology Quiz Case 1 [Clinical Problem Solving: Radiology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/828?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Klepac, N., Hajnsek, S., Topic, I., Zarkovic, K., Ozretic, D., Habek, M.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Otolaryngology/ Head & Neck Surgery, Hearing Loss/ Deafness, Neoplasms of Head & Neck, Radiology of Head & Neck, Skull Base Procedures, Diagnosis]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.89-a</dc:identifier>
<dc:title><![CDATA[Radiology Quiz Case 1 [Clinical Problem Solving: Radiology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>828</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>828</prism:startingPage>
<prism:section>Clinical Problem Solving: Radiology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/829?rss=1">
<title><![CDATA[Radiology Quiz Case 2 [Clinical Problem Solving: Radiology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/829?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Way, T. J., Weinberger, P. M., McKinnon, B. J.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Radiology of Head & Neck, Otolaryngology/ Head & Neck Surgery, Other, Diagnosis]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.90-a</dc:identifier>
<dc:title><![CDATA[Radiology Quiz Case 2 [Clinical Problem Solving: Radiology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>829</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>829</prism:startingPage>
<prism:section>Clinical Problem Solving: Radiology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/830?rss=1">
<title><![CDATA[Radiology Quiz Case 1: Diagnosis [Clinical Problem Solving: Radiology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/830?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Otolaryngology/ Head & Neck Surgery, Hearing Loss/ Deafness, Neoplasms of Head & Neck, Radiology of Head & Neck, Skull Base Procedures, Diagnosis]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.89-b</dc:identifier>
<dc:title><![CDATA[Radiology Quiz Case 1: Diagnosis [Clinical Problem Solving: Radiology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>830</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>830</prism:startingPage>
<prism:section>Clinical Problem Solving: Radiology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/831?rss=1">
<title><![CDATA[Radiology Quiz Case 2: Diagnosis [Clinical Problem Solving: Radiology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/831?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Radiology of Head & Neck, Otolaryngology/ Head & Neck Surgery, Other, Diagnosis]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.90-b</dc:identifier>
<dc:title><![CDATA[Radiology Quiz Case 2: Diagnosis [Clinical Problem Solving: Radiology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>831</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>831</prism:startingPage>
<prism:section>Clinical Problem Solving: Radiology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/832?rss=1">
<title><![CDATA[Pathology Quiz Case 1 [Clinical Problem Solving: Pathology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/832?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Visaya, J. M., Chu, E. A., Schmieg, J., Iding, J. S., Koch, W. M.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Neoplasms of Head & Neck, Pathology of Head & Neck, Salivary Gland Disorders, Diagnosis]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.82-a</dc:identifier>
<dc:title><![CDATA[Pathology Quiz Case 1 [Clinical Problem Solving: Pathology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>832</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>832</prism:startingPage>
<prism:section>Clinical Problem Solving: Pathology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/833?rss=1">
<title><![CDATA[Pathology Quiz Case 2 [Clinical Problem Solving: Pathology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/833?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Cohen, M., Sercarz, J. A., Huang, C. K., Bhuta, S., Head, C. S.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Otolaryngology/ Head & Neck Surgery, Airway Obstruction, Neoplasms of Head & Neck, Pathology of Head & Neck, Diagnosis]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.83-a</dc:identifier>
<dc:title><![CDATA[Pathology Quiz Case 2 [Clinical Problem Solving: Pathology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>833</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>833</prism:startingPage>
<prism:section>Clinical Problem Solving: Pathology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/834?rss=1">
<title><![CDATA[Pathology Quiz Case 1: Diagnosis [Clinical Problem Solving: Pathology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/834?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:47 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Neoplasms of Head & Neck, Pathology of Head & Neck, Salivary Gland Disorders, Diagnosis]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.82-b</dc:identifier>
<dc:title><![CDATA[Pathology Quiz Case 1: Diagnosis [Clinical Problem Solving: Pathology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>834</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>834</prism:startingPage>
<prism:section>Clinical Problem Solving: Pathology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/835?rss=1">
<title><![CDATA[Pathology Quiz Case 2: Diagnosis [Clinical Problem Solving: Pathology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/835?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:48 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Otolaryngology/ Head & Neck Surgery, Airway Obstruction, Neoplasms of Head & Neck, Pathology of Head & Neck, Diagnosis]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.83-b</dc:identifier>
<dc:title><![CDATA[Pathology Quiz Case 2: Diagnosis [Clinical Problem Solving: Pathology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>835</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>835</prism:startingPage>
<prism:section>Clinical Problem Solving: Pathology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/836?rss=1">
<title><![CDATA[The Common Cold and Concurrent Otitis Media [Letters to the Editor]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/836?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Chonmaitree, T.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:48 PDT</dc:date>
<dc:subject><![CDATA[Viral Infections, Neurology, Neuro-otology, Otolaryngology/ Head & Neck Surgery, Middle/ External Ear Disorders, Pediatric Otolaryngology, Pediatrics, Pediatrics, Other, Pulmonary Diseases, Pulmonary Diseases, Other, Infectious Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.96</dc:identifier>
<dc:title><![CDATA[The Common Cold and Concurrent Otitis Media [Letters to the Editor]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>836</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>836</prism:startingPage>
<prism:section>Letters to the Editor</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/8/836-a?rss=1">
<title><![CDATA[The Common Cold and Concurrent Otitis Media--Reply [Letters to the Editor]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/8/836-a?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Alper, C. M., Winther, B., Mandel, E. M., Hendley, J. O., Doyle, W. J.]]></dc:creator>
<dc:date>Mon, 17 Aug 2009 12:51:48 PDT</dc:date>
<dc:subject><![CDATA[Viral Infections, Neurology, Neuro-otology, Otolaryngology/ Head & Neck Surgery, Middle/ External Ear Disorders, Pediatric Otolaryngology, Pediatrics, Pediatrics, Other, Pulmonary Diseases, Pulmonary Diseases, Other, Infectious Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.95</dc:identifier>
<dc:title><![CDATA[The Common Cold and Concurrent Otitis Media--Reply [Letters to the Editor]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>8</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>837</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>836</prism:startingPage>
<prism:section>Letters to the Editor</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/629?rss=1">
<title><![CDATA[Acapulco Sunset [About the Cover]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/629?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:51 PDT</dc:date>
<dc:identifier>info:doi/10.1001/archotol.135.7.629</dc:identifier>
<dc:title><![CDATA[Acapulco Sunset [About the Cover]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>629</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>629</prism:startingPage>
<prism:section>About the Cover</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/630?rss=1">
<title><![CDATA[About This Journal [About This Journal]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/630?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:51 PDT</dc:date>
<dc:title><![CDATA[About This Journal [About This Journal]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>630</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>630</prism:startingPage>
<prism:section>About This Journal</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/634?rss=1">
<title><![CDATA[Facial Nerve Palsy in Neonates Secondary to Forceps Use [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/634?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To characterize the presentation, treatment, and outcome of neonates presenting with facial nerve palsy resulting from forceps use.</p>
<p><b>Design&nbsp;</b> Retrospective medical chart review.</p>
<p><b>Setting&nbsp;</b> Two tertiary care pediatric hospitals.</p>
<p><b>Patients&nbsp;</b> Neonates with facial nerve palsy caused by forceps use born during the period of April 1, 1989, to April 1, 2005.</p>
<p><b>Main Outcome Measure&nbsp;</b> Resolution of facial nerve palsy.</p>
<p><b>Results&nbsp;</b> Twenty-eight cases of facial nerve palsy caused by forceps use were identified. The palsy was classified as mild to moderate according to the House-Brackman scale. Except in 1 neonate, no treatment was initiated in any of the patients. All 21 neonates with adequate long-term follow-up recovered fully after an average period of 24 days.</p>
<p><b>Conclusion&nbsp;</b> Because facial nerve palsy caused by forceps use is generally mild and is associated with a favorable outcome, treatment with corticosteroids or surgery is generally not required.</p>
]]></description>
<dc:creator><![CDATA[Duval, M., Daniel, S. J.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:52 PDT</dc:date>
<dc:subject><![CDATA[Neurology, Neuro-otology, Otolaryngology/ Head & Neck Surgery, Facial Nerve Disorders, Pediatric Otolaryngology, Pediatrics, Neonatology and Infant Care]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.69</dc:identifier>
<dc:title><![CDATA[Facial Nerve Palsy in Neonates Secondary to Forceps Use [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>636</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>634</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/636?rss=1">
<title><![CDATA[Error in Author Name in: Clinical Predictors of Quality of Life in Patients With Initial Differentiated Thyroid Cancers [Correction]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/636?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:52 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Oncology, Other, Otolaryngology/ Head & Neck Surgery, Endocrine Disease of Head & Neck, Neoplasms of Head & Neck, Quality of Life, Radiation Therapy, Prognosis/ Outcomes, Endocrine Diseases, Thyroid/ Parathyroid Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.81</dc:identifier>
<dc:title><![CDATA[Error in Author Name in: Clinical Predictors of Quality of Life in Patients With Initial Differentiated Thyroid Cancers [Correction]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>636</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>636</prism:startingPage>
<prism:section>Correction</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/638?rss=1">
<title><![CDATA[Suppurative Complications of Acute Otitis Media: Changes in Frequency Over Time [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/638?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To review the experience at the Children's Hospital of Philadelphia in the management of suppurative complications of acute otitis media from 2000 to 2007, with an emphasis on changes in frequency over time.</p>
<p><b>Design&nbsp;</b> Retrospective cohort study.</p>
<p><b>Setting&nbsp;</b> Academic, tertiary care children's hospital.</p>
<p><b>Patients&nbsp;</b> The study population comprised 87 children (age &lt;18 years) with acute mastoiditis treated at our institution over the period of January 1, 2000, to December 31, 2007. Acute mastoiditis was defined by evidence of inflammation in the middle ear space and signs of mastoid inflammation (postauricular swelling, redness, or tenderness) or radiographic evidence of destruction of mastoid air cells, sigmoid sinus thrombosis, or abscess formation. Patients with underlying cholesteatoma were excluded.</p>
<p><b>Main Outcome Measure&nbsp;</b> Frequency of cases of acute mastoiditis per year.</p>
<p><b>Results&nbsp;</b> The frequency of cases of acute mastoiditis at our institution was positively correlated with calendar time, both for all cases of acute mastoiditis (Spearman rank correlation, <I>r</I>&nbsp;=&nbsp;0.73; <I>P</I>&nbsp;=&nbsp;.04) and for cases of mastoid subperiosteal abscess (<I>r</I>&nbsp;=&nbsp;0.96; <I>P</I>&nbsp;&lt;&nbsp;.001).</p>
<p><b>Conclusions&nbsp;</b> We observed an increase in the frequency of cases of acute mastoiditis with subperiosteal abscess seen at our institution over the study period, controlling for case volume. These findings suggest an increase in incidence, although further population-based studies are required to definitively evaluate this possibility.</p>
]]></description>
<dc:creator><![CDATA[Thorne, M. C., Chewaproug, L., Elden, L. M.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:52 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Middle/ External Ear Disorders, Pediatric Otolaryngology, Pediatrics, Pediatrics, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.75</dc:identifier>
<dc:title><![CDATA[Suppurative Complications of Acute Otitis Media: Changes in Frequency Over Time [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>641</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>638</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/642?rss=1">
<title><![CDATA[Improved Behavior and Sleep After Adenotonsillectomy in Children With Sleep-Disordered Breathing: Long-term Follow-up [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/642?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To determine whether previously published changes are maintained over time in children after adenotonsillectomy for sleep-disordered breathing using the validated Pediatric Sleep Questionnaire (PSQ) and the Conners Parent Rating Scale-Revised: Short Form (CPRS-R:S).</p>
<p><b>Design&nbsp;</b> Prospective, nonrandomized interventional study.</p>
<p><b>Setting&nbsp;</b> Ambulatory surgery center affiliated with an academic medical center.</p>
<p><b>Patients&nbsp;</b> Long-term follow-up data were available (ranging from 2.4 to 3.6 years after adenotonsillectomy) for 44 of the 71 patients who completed our initial study comparing PSQ and CPRS-R:S data before and 6 months after surgery.</p>
<p><b>Interventions&nbsp;</b> Parents completed the PSQ and CPRS-R:S at least 2 years after surgery.</p>
<p><b>Main Outcome Measures&nbsp;</b> Follow-up PSQ data and long-term changes in age- and sex-adjusted T scores for all 4 CPRS-R:S behavior categories (oppositional behavior, cognitive problems or inattention, hyperactivity, and the attention-deficit/hyperactivity disorder [ADHD] index) were determined for each patient. Linear mixed models were used to analyze the data.</p>
<p><b>Results&nbsp;</b> Globally, across time, most variables remained below baseline levels (<I>P</I>&nbsp;&lt;&nbsp;.05). There was a significant increase in PSQ scores during follow-up, but over this period they did not reach baseline levels. Comparing short-term with long-term follow-up, the Conners scores in all behavioral categories did not increase significantly (ADHD index, <I>P</I>&nbsp;=&nbsp;.61; cognitive problems or inattention, <I>P</I>&nbsp;=&nbsp;.02; hyperactivity, <I>P</I>&nbsp;&lt;&nbsp;.001; and oppositional behavior, <I>P</I>&nbsp;&lt;&nbsp;.001). The ADHD index at long-term follow-up was not different from that at baseline, a finding that might be attributable to the high degree of variability in this measure.</p>
<p><b>Conclusions&nbsp;</b> Improvements in sleep experienced by children after adenotonsillectomy for sleep-disordered breathing were not as great 2.5 years after surgery as they were 6 months after surgery but were still significant compared with baseline levels. Improvements in behavior were maintained in all categories of the Conners scores except for the ADHD index.</p>
]]></description>
<dc:creator><![CDATA[Wei, J. L., Bond, J., Mayo, M. S., Smith, H. J., Reese, M., Weatherly, R. A.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:52 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Pediatric Otolaryngology, Sleep Apnea, Otolaryngology/ Head & Neck Surgery, Other, Pediatrics, Pediatrics, Other, Prognosis/ Outcomes]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.74</dc:identifier>
<dc:title><![CDATA[Improved Behavior and Sleep After Adenotonsillectomy in Children With Sleep-Disordered Breathing: Long-term Follow-up [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>646</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>642</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/647?rss=1">
<title><![CDATA[Synchronous Airway Lesions and Outcomes in Infants With Severe Laryngomalacia Requiring Supraglottoplasty [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/647?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To quantify the prevalence and the impact of synchronous airway lesions identified by endoscopy in infants undergoing supraglottoplasty for severe laryngomalacia (LM).</p>
<p><b>Design&nbsp;</b> Retrospective study.</p>
<p><b>Setting&nbsp;</b> Tertiary care pediatric hospital.</p>
<p><b>Patients&nbsp;</b> Sixty patients who underwent supraglottoplasty for severe LM from 2002 to 2006. Patients who underwent preoperative tracheotomy, had previous airway surgery, or did not have 6 months of follow-up were excluded. Fifty-two patients met inclusion criteria.</p>
<p><b>Intervention&nbsp;</b> Supraglottoplasty (with carbon dioxide laser).</p>
<p><b>Main Outcome Measures&nbsp;</b> Presence of synchronous airway lesions and their contribution to upper airway obstruction (UAO) and their effect on the postoperative course after supraglottoplasty.</p>
<p><b>Results&nbsp;</b> Fifty-eight percent of patients had synchronous airway lesions (SALs), of whom 77% had subglottic stenosis (SGS) and 47% had tracheomalacia, bronchomalacia, or both. Sixty-three percent of all patients required postoperative nonsurgical airway support. Eight patients had residual UAO requiring additional surgical intervention, with 3 revision supraglottoplasties and 7 tracheotomies performed. Infants with neurological conditions had a high rate of surgical intervention (55%; <I>P</I>&nbsp;=&nbsp;.001). Patients with SGS exceeding 35% but without any neurological condition had a prolonged hospital stay (>3.6 days; <I>P</I>&nbsp;=&nbsp;.02) and an 83% incidence (<I>P</I>&nbsp;=&nbsp;.04) of postoperative UAO requiring intubation. Infants with LM with laryngeal edema (LE) alone had increased frequency of postoperative nonsurgical airway support (<I>P</I>&nbsp;=&nbsp;.02) and a prolonged hospital stay of 1 day (<I>P</I>&nbsp;=&nbsp;.01) compared with infants without edema.</p>
<p><b>Conclusions&nbsp;</b> There is a high incidence of SALs in patients undergoing supraglottoplasty. Neurological conditions, hypoplastic mandible, SGS greater than 35%, and preexisting LE independently adversely affected the postoperative course.</p>
]]></description>
<dc:creator><![CDATA[Schroeder, J. W., Bhandarkar, N. D., Holinger, L. D.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:52 PDT</dc:date>
<dc:subject><![CDATA[Neurology, Pediatric Neurology, Otolaryngology/ Head & Neck Surgery, Laryngology/ Speech/ Language Pathology, Pediatric Otolaryngology, Pediatrics, Pediatrics, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.73</dc:identifier>
<dc:title><![CDATA[Synchronous Airway Lesions and Outcomes in Infants With Severe Laryngomalacia Requiring Supraglottoplasty [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>651</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>647</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/652?rss=1">
<title><![CDATA[Velopharyngoplasty for Noncleft Velopharyngeal Insufficiency: Results in Relation to 22q11 Microdeletion [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/652?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To evaluate the results of velopharyngoplasty for velopharyngeal insufficiency (VPI) in relation to 22q11 deletion or nonsyndromic VPI.</p>
<p><b>Design&nbsp;</b> Retrospective study.</p>
<p><b>Setting&nbsp;</b> Academic medical center.</p>
<p><b>Patients&nbsp;</b> Eleven of 45 patients with 22q11 microdeletion (group 1) and 9 patients without 22q11 microdeletion (group 2) with noncleft VPI (hypoplastic velum or hypodynamic velopharynx and deep pharynx) underwent velopharyngoplasty (midline pharyngeal flap with superior pedicle). Exclusion criteria included cleft palate, submucous cleft palate, all syndromic cases, and all associated malformations (except those related to 22q11 microdeletion in patients with DiGeorge syndrome).</p>
<p><b>Main Outcome Measures&nbsp;</b> Speech assessment before surgery using the Borel-Maisonny scale and at 9 months and 24 months after surgery. Velopharyngeal insufficiency was classified as normal, inconsistent, mild, moderate, and severe.</p>
<p><b>Results&nbsp;</b> Before surgery, in group 1, 3 patients had mild and 8 had severe VPI, and in group 2, 1 had mild and 8 had severe VPI. Postoperative outcomes at 9 months showed that in group 1, 2 patients had excellent results (normal and inconsistent) and 9 had mild VPI, while in group 2, 6 patients had excellent results and 3 had mild VPI (<I>P</I>&nbsp;=&nbsp;.03). Postoperative outcomes at 24 months showed that in group 1, 10 patients had excellent results and 1 had mild VPI, while in group 2, 8 patients had excellent results and 1 had mild VPI.</p>
<p><b>Conclusions&nbsp;</b> Surgical treatment of noncleft VPI by pharyngoplasty was efficient in 10 of the 11 patients (91%) in the 22q11 group and in 8 of the 9 patients (89%) in the nonsyndromic group. Postoperative remission took longer for patients with the 22q11 microdeletion than for the control group. However, long-term results following surgical treatment were equally good in the 2 groups.</p>
]]></description>
<dc:creator><![CDATA[Rouillon, I., Leboulanger, N., Roger, G., Maulet, M., Marlin, S., Loundon, N., Portnoi, M. F., Denoyelle, F., Garabedian, E. N.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:52 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Congenital Anomalies of Head & Neck, Genetics of Head & Neck Disease, Pediatric Otolaryngology, Otolaryngology/ Head & Neck Surgery, Other, Pediatrics, Congenital Malformations, Pediatrics, Other, Surgery, Surgical Interventions, Pediatric Surgery, Prognosis/ Outcomes]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.64</dc:identifier>
<dc:title><![CDATA[Velopharyngoplasty for Noncleft Velopharyngeal Insufficiency: Results in Relation to 22q11 Microdeletion [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>656</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>652</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/657?rss=1">
<title><![CDATA[Virulence of Pneumococcal Proteins on the Inner Ear [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/657?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To investigate the effects of the virulence characteristics of specific pneumococcal proteins on the inner ear.</p>
<p><b>Main Outcome Measures&nbsp;</b> A histologic comparison of inflammatory cell infiltration and pathologic changes in the round window membrane and inner ear.</p>
<p><b>Results&nbsp;</b> Most of the animals inoculated with high-dose pneumolysin or wild-type bacteria showed severe pathologic changes of the inner ears. The inner ears of most animals inoculated with surface protein A or surface antigen A&ndash;deficient bacteria appeared normal.</p>
<p><b>Conclusions&nbsp;</b> Pneumococcal surface protein A and pneumococcal surface antigen A are 2 important virulence factors in inner ear damage secondary to pneumococcal otitis media. Mutation of these virulence factors results in less inner ear damage.</p>
]]></description>
<dc:creator><![CDATA[Schachern, P. A., Tsuprun, V., Cureoglu, S., Ferrieri, P., Briles, D. E., Paparella, M. M., Juhn, S.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:52 PDT</dc:date>
<dc:subject><![CDATA[Bacterial Infections, Otolaryngology/ Head & Neck Surgery, Middle/ External Ear Disorders, Pediatric Otolaryngology, Pediatrics, Pediatrics, Other, Infectious Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.72</dc:identifier>
<dc:title><![CDATA[Virulence of Pneumococcal Proteins on the Inner Ear [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>661</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>657</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/662?rss=1">
<title><![CDATA[p73 Expression and Function in Vestibular Schwannoma [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/662?rss=1</link>
<description><![CDATA[
<p><b>Objectives&nbsp;</b> To determine the expression of the <I>p53</I> family member <I>p73</I> in vestibular schwannoma (VS) and to determine the potential role of this tumor suppressor in regulating the proliferation of HEI193, a human papillomavirus E6-E7 immortalized VS cell line.</p>
<p><b>Methods&nbsp;</b> Immunohistochemical staining was used to investigate the expression of p73 in 34 cases of archived VS tissue, while Western blot analysis and immunofluorescence were performed to demonstrate the expression and localization of p73 in HEI193. After transfection of a full-length p73 plasmid (TAp73), flow cytometry analysis was performed to determine the effect of p73 expression on cell cycle distribution, while annexin V&ndash;FITC (fluorescein isothiocyanate) analysis and TUNEL (terminal deoxynucleotidyltransferase-mediated dUTP nick-end labeling) assay were used to measure apoptosis. The effect of p73 expression on ionizing radiation&ndash;induced cell death was also investigated with annexin V staining, TUNEL assay, and flow cytometry analysis.</p>
<p><b>Results&nbsp;</b> Of the 34 vestibular schwannoma tissues examined, p73 was expressed in 14 (41%) but was not expressed in HEI193. Transfection of <I>p73</I> alone resulted in increased apoptosis and necrosis, and G<SUB>1</SUB> accumulation with concomitant induction of p21. The presence of p73 also significantly increased early apoptosis (<I>P</I>&nbsp;=&nbsp;.046), late apoptosis (<I>P</I>&nbsp;&lt;&nbsp;.001), and necrosis (<I>P</I>&nbsp;=&nbsp;.009) on exposure of the HEI193 cells to ionizing radiation.</p>
<p><b>Conclusion&nbsp;</b> Forced expression of <I>p73</I>, perhaps by gene therapy, to induce apoptosis directly or to sensitize VS tumors to ionizing radiation may have relevant therapeutic applications.</p>
]]></description>
<dc:creator><![CDATA[Ahmad, Z. K., Altuna, X., Lopez, J. P., An, Y., Wang-Rodriguez, J., Juneja, V. R., Chen, J. S., Arandazi, M. J., Aguilera, J., Harris, J. P., Ongkeko, W. M.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:52 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Otolaryngology/ Head & Neck Surgery, Genetics of Head & Neck Disease, Neoplasms of Head & Neck, Genetics, Genetic Counseling/ Testing/ Therapy]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.79</dc:identifier>
<dc:title><![CDATA[p73 Expression and Function in Vestibular Schwannoma [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>669</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>662</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/670?rss=1">
<title><![CDATA[Evaluation of the Thyroid in Patients With Hearing Loss and Enlarged Vestibular Aqueducts [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/670?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To evaluate thyroid structure and function in patients with enlargement of the vestibular aqueduct (EVA) and sensorineural hearing loss.</p>
<p><b>Design&nbsp;</b> Prospective cohort survey.</p>
<p><b>Setting&nbsp;</b> National Institutes of Health Clinical Center, a federal biomedical research facility.</p>
<p><b>Patients&nbsp;</b> The study population comprised 80 individuals, aged 1.5 to 59 years, ascertained on the basis of EVA and sensorineural hearing loss.</p>
<p><b>Main Outcome Measures&nbsp;</b> Associations among the number of mutant alleles of <I>SLC26A4</I>; volume and texture of the thyroid; percentage of iodine 123 (<sup>123</sup>I) discharged at 120 minutes after administration of perchlorate in the perchlorate discharge test; and peripheral venous blood levels of thyrotropin, thyroxine, free thyroxine, triiodothyronine, thyroglobulin, antithyroid peroxidase and antithyroglobulin antibodies, and thyroid-binding globulin.</p>
<p><b>Results&nbsp;</b> Thyroid volume is primarily genotype dependent in pediatric patients but age dependent in older patients. Individuals with 2 mutant <I>SLC26A4</I> alleles discharged a significantly (<I>P</I>&nbsp;&le;&nbsp;.001) greater percentage of <sup>123</sup>I compared with those with no mutant alleles or 1 mutant allele. Thyroid function, as measured by serologic testing, is not associated with the number of mutant alleles.</p>
<p><b>Conclusions&nbsp;</b> Ultrasonography with measurement of gland volume is recommended for initial assessment and follow-up surveillance of the thyroid in patients with EVA. Perchlorate discharge testing is recommended for the diagnostic evaluation of patients with EVA along with goiter, nondiagnostic <I>SLC26A4</I> genotypes (zero or 1 mutant allele), or both.</p>
]]></description>
<dc:creator><![CDATA[Madeo, A. C., Manichaikul, A., Reynolds, J. C., Sarlis, N. J., Pryor, S. P., Shawker, T. H., Griffith, A. J.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:52 PDT</dc:date>
<dc:subject><![CDATA[Neurology, Neuro-otology, Otolaryngology/ Head & Neck Surgery, Endocrine Disease of Head & Neck, Genetics of Head & Neck Disease, Hearing Loss/ Deafness, Endocrine Diseases, Thyroid/ Parathyroid Diseases, Genetics, Genetic Disorders]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.66</dc:identifier>
<dc:title><![CDATA[Evaluation of the Thyroid in Patients With Hearing Loss and Enlarged Vestibular Aqueducts [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>676</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>670</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/677?rss=1">
<title><![CDATA[Three-dimensional Educational Computer Model of the Larynx: Voicing a New Direction [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/677?rss=1</link>
<description><![CDATA[
<p><b>Objectives&nbsp;</b> To create a 3-dimensional (3D) educational computer model of the larynx, to assess the feasibility of this learning module on a Web-based platform, and to obtain student feedback on the module.</p>
<p><b>Design&nbsp;</b> Male and female adult cadaveric necks were scanned with microcomputed tomographic and magnetic resonance imaging scanners. Key structures were identified on each slice of the computed tomogram and/or magnetic resonance image and analyzed with a segmentation software package. Then, the images were exported into Microsoft Powerpoint. Visual text and audio commentary were added. Real cases of a child's larynx, an adult with a tracheostomy, and a patient with laryngeal carcinoma were included. The computer module was launched on a password-protected, Web-based platform.</p>
<p><b>Participants&nbsp;</b> Fifty-eight first-year medical students (38% male; mean [SD] age, 23 [1.8] years) were invited to evaluate the module and to complete a survey.</p>
<p><b>Results&nbsp;</b> Most students thought that the 3D computer module was effective (60%), clear (66%), and user friendly (72%); most students (81%) thought that it was easier to understand laryngeal anatomy when they could visualize it in 3D; and most students (83%) said that they would like lectures better if they were supplemented with 3D computer modules.</p>
<p><b>Conclusion&nbsp;</b> A 3D educational computer model of the larynx has been successfully created and warmly received by medical students.</p>
]]></description>
<dc:creator><![CDATA[Hu, A., Wilson, T., Ladak, H., Haase, P., Fung, K.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:52 PDT</dc:date>
<dc:subject><![CDATA[Informatics/ Internet in Medicine, Internet, Medical Practice, Medical Education, Otolaryngology/ Head & Neck Surgery, Laryngology/ Speech/ Language Pathology]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.68</dc:identifier>
<dc:title><![CDATA[Three-dimensional Educational Computer Model of the Larynx: Voicing a New Direction [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>681</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>677</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/682?rss=1">
<title><![CDATA[Correlation Between Intraoperative Hypothermia and Perioperative Morbidity in Patients With Head and Neck Cancer [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/682?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To determine if intraoperative hypothermia correlates with perioperative complications in patients undergoing head and neck surgery with regional or free flap reconstructions.</p>
<p><b>Design&nbsp;</b> Retrospective medical chart review.</p>
<p><b>Setting&nbsp;</b> Academic tertiary care hospital.</p>
<p><b>Patients&nbsp;</b> A sample of 136 patients who underwent ablative surgery for head and neck cancer and subsequently required reconstruction with free tissue or a regional flap in the last 10 years.</p>
<p><b>Main Outcome Measures&nbsp;</b> Rate of early (within 3 weeks of surgery) perioperative complications and its correlation with patient hypothermia (core body temperature, &lt;35&deg;C).</p>
<p><b>Results&nbsp;</b> There were 43 patients with complications. Two patients died. Complications included 10 partial or total flap losses, 9 hematomas, 8 episodes of pneumonia, 7 fistulas, 7 wound infections, 5 wound breakdowns, and 2 cerebrospinal fluid leaks. Factors that did not correlate with complications included having received prior chemotherapy (<I>P</I>&nbsp;=&nbsp;.84), having stage IV cancer (<I>P</I>&nbsp;=&nbsp;.16), sex (<I>P</I>&nbsp;=&nbsp;.43), tobacco use (<I>P</I>&nbsp;=&nbsp;.58), prior radiotherapy (<I>P</I>&nbsp;=&nbsp;.30), the presence of comorbidities (<I>P</I>&nbsp;=&nbsp;.43), age (<I>P</I>&nbsp;=&nbsp;.27), length of surgery (<I>P</I>&nbsp;=&nbsp;.63), and the use of blood products perioperatively (<I>P</I>&nbsp;=&nbsp;.73). Patients who were hypothermic had a significantly higher rate of complications that normothermic patients (<I>P</I>&nbsp;=&nbsp;.002). Stepwise logistic regression analysis identified intraoperative hypothermia as a significant independent predictor for the development of early perioperative complications (odds ratio, 5.122; 95% confidence interval, 1.317-19.917).</p>
<p><b>Conclusions&nbsp;</b> Intraoperative hypothermia in head and neck surgery is correlated with perioperative complications. Maintaining normothermia through aggressive warming may decrease the incidence of perioperative morbidity for these patients.</p>
]]></description>
<dc:creator><![CDATA[Sumer, B. D., Myers, L. L., Leach, J., Truelson, J. M.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:52 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Otolaryngology/ Head & Neck Surgery, Cancer Reconstruction of Head & Neck, Neoplasms of Head & Neck, Facial Plastic Surgery, Reconstructive Facial Surgery]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.65</dc:identifier>
<dc:title><![CDATA[Correlation Between Intraoperative Hypothermia and Perioperative Morbidity in Patients With Head and Neck Cancer [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>686</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>682</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/686?rss=1">
<title><![CDATA[Call for Photographs [Announcement]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/686?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:52 PDT</dc:date>
<dc:identifier>info:doi/10.1001/archoto.2008.686</dc:identifier>
<dc:title><![CDATA[Call for Photographs [Announcement]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>686</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>686</prism:startingPage>
<prism:section>Announcement</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/687?rss=1">
<title><![CDATA[Outcomes of Postoperative Concurrent Chemoradiotherapy for Locally Advanced Major Salivary Gland Carcinoma [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/687?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To investigate the potential value of postoperative concurrent chemoradiation among patients with high-risk salivary gland carcinomas.</p>
<p><b>Design&nbsp;</b> Case control study based on retrospective medical record review.</p>
<p><b>Setting&nbsp;</b> A tertiary care comprehensive cancer center.</p>
<p><b>Patients&nbsp;</b> A total of 24 patients, 12 with major salivary gland carcinoma who were treated with postoperative concurrent chemoradiotherapy from 1998 to 2007 (chemoradiation group), and a control group of 12 patients treated with postoperative radiation alone.</p>
<p><b>Main Outcome Measures&nbsp;</b> Overall survival, progression-free survival, toxic effects.</p>
<p><b>Results&nbsp;</b> All but 1 patient had stage III or IV disease; close or positive surgical margins were identified in 20 patients (83%). The median radiation dose was 63 Gy. In the chemoradiation group, platinum-based regimens were used in all. Treatment was well tolerated, but toxic effects, predominantly hematologic, were increased in the chemoradiation group. To date, 8 patients have died; the median overall survival was 53 months. The overall survival in the chemoradiation group was significantly better than in the radiation-alone group: 3-year survival rates were 83% and 44%, respectively (<I>P</I>&nbsp;=&nbsp;.05).</p>
<p><b>Conclusions&nbsp;</b> Locally advanced or high-grade salivary gland carcinomas follow an aggressive clinical course. Based on our limited experience, postoperative chemoradiation with a platinum-based regimen seems to be effective in selected patients and warrants further investigation.</p>
]]></description>
<dc:creator><![CDATA[Tanvetyanon, T., Qin, D., Padhya, T., McCaffrey, J., Zhu, W., Boulware, D., DeConti, R., Trotti, A.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:52 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Oncology, Other, Otolaryngology/ Head & Neck Surgery, Neoplasms of Head & Neck, Salivary Gland Disorders, Radiation Therapy, Prognosis/ Outcomes, Drug Therapy, Drug Therapy, Other]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.70</dc:identifier>
<dc:title><![CDATA[Outcomes of Postoperative Concurrent Chemoradiotherapy for Locally Advanced Major Salivary Gland Carcinoma [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>692</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>687</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/694?rss=1">
<title><![CDATA[Use of Combination Proteomic Analysis to Demonstrate Molecular Similarity of Head and Neck Squamous Cell Carcinoma Arising From Different Subsites [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/694?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To evaluate head and neck squamous cell carcinomas (HNSCCs) for differences in protein expression between oral cavity, oropharynx, larynx, and hypopharynx subsites.</p>
<p><b>Design&nbsp;</b> Retrospective proteomic analysis using tissue microarray (TMA) and 2-dimensional difference gel electrophoresis (2D-DIGE). For the TMA, automated quantitative protein expression analysis was used to interrogate levels of 4 cell-cycle regulatory proteins chosen for their known roles in cancer (cyclin D1, p53, Rb, and p14). For the 2D-DIGE, lesional and normal adjacent tissues were enriched by laser capture microdissection. Total protein was extracted, analyzed by 2D-DIGE with saturation dye labeling, and evaluated for relative abundance levels of individual protein spots.</p>
<p><b>Setting&nbsp;</b> Two tertiary-care academic medical centers.</p>
<p><b>Patients&nbsp;</b> Seventy-one patients with HNSCC for TMA, and 14 patients with HNSCC with frozen tumor and normal tissue for 2D-DIGE.</p>
<p><b>Results&nbsp;</b> The automated quantitative analysis of protein expression analysis revealed no difference between subsite for cyclin D1, p53, Rb, or p14 expression. The 2D-DIGE study was based on 28 gels (14 cancer gels and 14 adjacent normal gels), and 732 spots were identified as matching across more than 90% of gels. Significance was evaluated based on false discovery rate (FDR) estimated from permuted data sets. There were no significant differences in protein expression between subsites (FDR greater than or equal to 30% in all instances).</p>
<p><b>Conclusions&nbsp;</b> Observed differences in outcomes between HNSCCs from different subsites may not reflect differences in tumor biologic characteristics between subsites. Rather, it is possible that observed clinical heterogeneity among HNSCCs may be based on other factors, such as viral vs chemical carcinogenesis.</p>
]]></description>
<dc:creator><![CDATA[Weinberger, P. M., Merkley, M., Lee, J. R., Adam, B.-L., Gourin, C. G., Podolsky, R. H., Haffty, B. G., Papadavid, E., Sasaki, C., Psyrri, A., Dynan, W. S.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:52 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Dentistry/ Oral Medicine, Otolaryngology/ Head & Neck Surgery, Genetics of Head & Neck Disease, Laryngology/ Speech/ Language Pathology, Neoplasms of Head & Neck]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.78</dc:identifier>
<dc:title><![CDATA[Use of Combination Proteomic Analysis to Demonstrate Molecular Similarity of Head and Neck Squamous Cell Carcinoma Arising From Different Subsites [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>703</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>694</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/704?rss=1">
<title><![CDATA[Speech Intelligibility, Acceptability, and Communication-Related Quality of Life in Chinese Alaryngeal Speakers [Original Article]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/704?rss=1</link>
<description><![CDATA[
<p><b>Objective&nbsp;</b> To investigate (1) speech intelligibility and acceptability in using 4 different alaryngeal speech methods: esophageal (ES), electrolaryngeal (EL), pneumatic device (PD), and tracheosophageal (TE) speech; and (2) communication-related quality of life (QOL) in the alaryngeal speakers who used these 4 alaryngeal speech methods.</p>
<p><b>Design&nbsp;</b> Survey.</p>
<p><b>Participants&nbsp;</b> Alaryngeal speakers who had undergone speech rehabilitation and were recruited from the New Voice Club of Hong Kong.</p>
<p><b>Main Outcome Measures&nbsp;</b> Speech samples collected from 49 alaryngeal speakers were rated by 6 judges for speech intelligibility and acceptability. The speakers also completed a communication-related QOL questionnaire called the Communication Activity and Participation After Laryngectomy.</p>
<p><b>Results&nbsp;</b> We found that the ES and EL speakers showed considerably poorer speech intelligibility and communication-related QOL. The PD speakers demonstrated notably better speech intelligibility and acceptability ratings. However, high intelligibility and acceptability do not necessarily mean better QOL. The TE speakers, who demonstrated only the second highest speech intelligibility and acceptability, showed the best functional QOL.</p>
<p><b>Conclusion&nbsp;</b> In speech rehabilitation after laryngectomy, QOL and speech intelligibility and acceptability should be considered together to find a balance that is acceptable to the patient.</p>
]]></description>
<dc:creator><![CDATA[Law, I. K.-Y., Ma, E. P.-M., Yiu, E. M.-L.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:52 PDT</dc:date>
<dc:subject><![CDATA[Neurology, Behavioral Neurology, Otolaryngology/ Head & Neck Surgery, Laryngology/ Speech/ Language Pathology, Patient-Physician Relationship/ Care, Psychosocial Issues, Quality of Life, Rehabilitation Medicine]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.71</dc:identifier>
<dc:title><![CDATA[Speech Intelligibility, Acceptability, and Communication-Related Quality of Life in Chinese Alaryngeal Speakers [Original Article]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>711</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>704</prism:startingPage>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/712?rss=1">
<title><![CDATA[Parathyroid Adenoma as a Cause of Vocal Fold Paralysis [Clinical Note]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/712?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Lee, J.-C., Barkdull, G. C., Weisman, R. A.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:52 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Otolaryngology/ Head & Neck Surgery, Endocrine Disease of Head & Neck, Neoplasms of Head & Neck, Voice Disorders, Endocrine Diseases, Thyroid/ Parathyroid Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.60</dc:identifier>
<dc:title><![CDATA[Parathyroid Adenoma as a Cause of Vocal Fold Paralysis [Clinical Note]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>713</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>712</prism:startingPage>
<prism:section>Clinical Note</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/714?rss=1">
<title><![CDATA[The Otolaryngologic Features of Sanjad-Sakati Syndrome [Clinical Note]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/714?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Tanna, N., Preciado, D. A., Biran, N.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:52 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Airway Obstruction, Congenital Anomalies of Head & Neck, Genetics of Head & Neck Disease, Pediatric Otolaryngology, Sleep Apnea, Pediatrics, Congenital Malformations, Pulmonary Diseases, Pulmonary Diseases, Other, Surgery, Surgical Interventions, Thoracic Surgery]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.76</dc:identifier>
<dc:title><![CDATA[The Otolaryngologic Features of Sanjad-Sakati Syndrome [Clinical Note]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>715</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>714</prism:startingPage>
<prism:section>Clinical Note</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/716?rss=1">
<title><![CDATA[Radiology Quiz Case 1 [Clinical Problem Solving: Radiology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/716?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Wu, P.-Y., Friedman, M., Huang, S.-C., Lin, H.-C.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:52 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Congenital Anomalies of Head & Neck, Radiology of Head & Neck, Pediatrics, Congenital Malformations, Radiologic Imaging, Diagnosis, Computed Tomography]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.58-a</dc:identifier>
<dc:title><![CDATA[Radiology Quiz Case 1 [Clinical Problem Solving: Radiology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>716</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>716</prism:startingPage>
<prism:section>Clinical Problem Solving: Radiology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/717?rss=1">
<title><![CDATA[Radiology Quiz Case 2 [Clinical Problem Solving: Radiology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/717?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[van de Langenberg, R., Stokroos, R., de Bondt, B.-J.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:52 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Lung Cancer, Oncology, Other, Otolaryngology/ Head & Neck Surgery, Neoplasms of Head & Neck, Radiology of Head & Neck, Pulmonary Diseases, Pulmonary Diseases, Other, Radiologic Imaging, Diagnosis, Magnetic Resonance Imaging]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.59-a</dc:identifier>
<dc:title><![CDATA[Radiology Quiz Case 2 [Clinical Problem Solving: Radiology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>717</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>717</prism:startingPage>
<prism:section>Clinical Problem Solving: Radiology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/718?rss=1">
<title><![CDATA[Radiology Quiz Case 1: Diagnosis [Clinical Problem Solving: Radiology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/718?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:52 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, Congenital Anomalies of Head & Neck, Radiology of Head & Neck, Pediatrics, Congenital Malformations, Radiologic Imaging, Diagnosis, Computed Tomography]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.58-b</dc:identifier>
<dc:title><![CDATA[Radiology Quiz Case 1: Diagnosis [Clinical Problem Solving: Radiology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>718</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>718</prism:startingPage>
<prism:section>Clinical Problem Solving: Radiology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/719?rss=1">
<title><![CDATA[Radiology Quiz Case 2: Diagnosis [Clinical Problem Solving: Radiology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/719?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:52 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Lung Cancer, Oncology, Other, Otolaryngology/ Head & Neck Surgery, Neoplasms of Head & Neck, Radiology of Head & Neck, Pulmonary Diseases, Pulmonary Diseases, Other, Radiologic Imaging, Diagnosis, Magnetic Resonance Imaging]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.59-b</dc:identifier>
<dc:title><![CDATA[Radiology Quiz Case 2: Diagnosis [Clinical Problem Solving: Radiology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>719</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>719</prism:startingPage>
<prism:section>Clinical Problem Solving: Radiology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/720?rss=1">
<title><![CDATA[Pathology Quiz Case 1 [Clinical Problem Solving: Pathology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/720?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Monroe, M. M., Sauer, D. A., Samuels, M. H., Gross, N. D.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:52 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Otolaryngology/ Head & Neck Surgery, Endocrine Disease of Head & Neck, Neoplasms of Head & Neck, Pathology of Head & Neck, Surgery, Surgical Interventions, Endocrine Surgery, Diagnosis, Endocrine Diseases, Thyroid/ Parathyroid Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.62-a</dc:identifier>
<dc:title><![CDATA[Pathology Quiz Case 1 [Clinical Problem Solving: Pathology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>720</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>720</prism:startingPage>
<prism:section>Clinical Problem Solving: Pathology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/721?rss=1">
<title><![CDATA[Pathology Quiz Case 2 [Clinical Problem Solving: Pathology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/721?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Syed, I., Smithard, A., Sharif, H., Bleach, N.]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:52 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, General Rhinology, Pathology of Head & Neck, Diagnosis]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.63-a</dc:identifier>
<dc:title><![CDATA[Pathology Quiz Case 2 [Clinical Problem Solving: Pathology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>721</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>721</prism:startingPage>
<prism:section>Clinical Problem Solving: Pathology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/722?rss=1">
<title><![CDATA[Pathology Quiz Case 1: Diagnosis [Clinical Problem Solving: Pathology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/722?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:52 PDT</dc:date>
<dc:subject><![CDATA[Oncology, Head & Neck Cancer, Otolaryngology/ Head & Neck Surgery, Endocrine Disease of Head & Neck, Neoplasms of Head & Neck, Pathology of Head & Neck, Surgery, Surgical Interventions, Endocrine Surgery, Diagnosis, Endocrine Diseases, Thyroid/ Parathyroid Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.62-b</dc:identifier>
<dc:title><![CDATA[Pathology Quiz Case 1: Diagnosis [Clinical Problem Solving: Pathology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>722</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>722</prism:startingPage>
<prism:section>Clinical Problem Solving: Pathology</prism:section>
</item>

<item rdf:about="http://archotol.ama-assn.org/cgi/content/short/135/7/723?rss=1">
<title><![CDATA[Pathology Quiz Case 2: Diagnosis [Clinical Problem Solving: Pathology]]]></title>
<link>http://archotol.ama-assn.org/cgi/content/short/135/7/723?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 20 Jul 2009 12:54:52 PDT</dc:date>
<dc:subject><![CDATA[Otolaryngology/ Head & Neck Surgery, General Rhinology, Pathology of Head & Neck, Diagnosis]]></dc:subject>
<dc:identifier>info:doi/10.1001/archoto.2009.63-b</dc:identifier>
<dc:title><![CDATA[Pathology Quiz Case 2: Diagnosis [Clinical Problem Solving: Pathology]]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>135</prism:volume>
<prism:endingPage>723</prism:endingPage>
<prism:publicationDate>2009-07-01</prism:publicationDate>
<prism:startingPage>723</prism:startingPage>
<prism:section>Clinical Problem Solving: Pathology</prism:section>
</item>

</rdf:RDF>